Monday
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
$166.72 / -11.14 (-6.26%)
01/25/23 Tesla extends afterhours gains, up over 5% at $152.45 01/25/23 Tesla CEO says Dojo AI to be competitive with Nvidia at end of 2023 01/25/23 Tesla CEO says we have other products in development 01/25/23 Tesla's Musk says probably will have 'difficult recession this year' 12/14/22 SoFi Technologies spikes over 8% after CEO Noto buys $5M in shares 12/13/22 SoFi Technologies CEO buys $5M in common stock 11/21/22 SoFi says cryptocurrency 'non-material component' of business 11/21/22 Sen. Brown, colleagues ask bank regulators to review SoFi's crypto activities 01/30/23 Regeneron, Sanofi announce EC expansion of Dupixent marketing authorization 01/27/23 Regeneron, Sanofi announce CHMP opinion recommending EU approval for Dupixent 01/06/23 2seventy Bio announces amendment to collaboration with Regeneron 01/05/23 CytomX Therapeutics updates business, announces 2023 relationship with Moderna 01/30/23 Philips sees FY23 comparable sales up low-single-digits 01/30/23 Philips to reduce workforce by additional 3,000 roles in 2023, 6,000 by 2025 01/18/23 Masimo, Philips expands partnership to improve telehealth for patients 12/21/22 Philips gives update on test, research program of PE-PUR sound abatement foam 01/12/23 Okta says there will be some disruption from sales leadership changes 01/12/23 authID integrates Verified CloudConnect with Okta Workforce Identity Cloud 12/21/22 Okta says code repositories copied in early December GitHub hack 11/15/22 Okta debuts 'Okta for US Military' purpose-built identity environment for DoD 01/09/23 Macy's falls -9.0% 01/06/23 Macy's falls 4% to $21.23 after guiding Q4 sales to low-end to midpoint of range 11/17/22 Macy's rises 12.2% 11/17/22 Macy's rises 9.5% 01/26/23 Southwest says it continues to experience year-over-year inflationary pressures 01/26/23 Southwest plans to add 7,000 workers in 2023 01/26/23 Southwest sees FY23 economic fuel costs per gallon $2.90-$3.00 01/23/23 Southwest dispatch staff reaches tentative agreement on contract 01/27/23 Lucid Group trading resumes 01/27/23 Lucid Group trading halted, volatility trading pause 01/27/23 Lucid Group jumps 8% to $9.75 after Betaville mention 01/27/23 Lucid Motors opens first retail studio, service center in Montreal, Quebec 11/14/22 Starboard takes stake in Wix.com, exits Elanco Animal Health 11/14/22 Appaloosa exits positions in Kohl's, Occidental Petroleum, Micron 11/08/22 Ancora supports management transition at Kohl's 11/08/22 Levi Strauss appoints Michelle Gass as President, to succeed Bergh as CEO $139.13 / -1.135 (-0.81%)
01/20/23 JPMorgan Asset Management receives approval for 100% ownership of China JV 01/13/23 JPMorgan says continues to expect 17% ROTCE in 2023 01/13/23 JPMorgan says targeting potential $12B in share buybacks in 2023 01/13/23 JPMorgan says investment banking pipeline 'relatively robust' 01/30/23 Johnson & Johnson falls after court rejects bankruptcy plan for talc lawsuits 01/30/23 J&J drops 3% after court rejects bankruptcy plan for talc lawsuits 01/27/23 Janssen announces unblinding of Phase 3 CARTITUDE-4 study of CARVYKTI 01/24/23 Johnson & Johnson says assuming a lot of inflationary carryover in 2023 10/04/22 Golden Ocean board authorizes $100M share buy-back program 01/30/23 GM Defense, American Rheinmetall win contract for U.S. Army's CTT Program 01/20/23 GM investing $918M in four U.S. facilities for V-8 engines, EV components 01/10/23 RMI launches virtual power plant partnership with GM, Google, Ford 01/23/23 GE HealthCare, Windsor Regional Hospital enter long-term MES agreement 01/09/23 GE HealthCare announces acquisition of CT firm Imactis, terms undisclosed 01/09/23 GE HealthCare to acquire IMACTIS, terms not disclosed 01/05/23 GE HealthCare names Taha Kass-Hout CTO 01/06/23 Flora Growth receives 180 day extension to regain compliance with Nasdaq 01/05/23 Flora Growth provides update on commercial cannabis operations in Colombia 11/14/22 Flora Growth partners with 357 Company to launch 357 Canna Logistics 10/24/22 Flora Growth to acquire medical cannabis Franchise Global Health 01/30/23 Ford to 'significantly increase' Mustang Mach-E production, cut prices 01/26/23 Ford expands complimentary pick-up & delivery mobile service nationwide 01/23/23 Ford sees Q4 pre-tax remeasurement gain of roughly $50M from pension, OPEB plans 01/18/23 EU passenger car registrations up 12.8% in December 08/24/22 Dynex Capital CFO buys $158.4K in common stock 01/18/23 Ginkgo Bioworks and NAMUH announce collaboration to develop HMOs 01/17/23 Ginkgo Bioworks, Xwell expand support for CDC's Genomic Surveillance program 01/17/23 Ginkgo Bioworks and Xwell partner in influenza variant detection for CDC 01/09/23 Ginkgo Bioworks, Prokarium announce RNA collaboration 01/30/23 Colgate-Palmolive names Steve Cahillane to Board of Directors 11/14/22 Third Point buys TJX, exits Cenovus Energy in Q3 10/28/22 Colgate-Palmolive CEO says negative impact from currency accelerated in Q3 10/28/22 Colgate-Palmolive reports Q3 gross profit margin 57.2%, down 220 bps 10/21/22 Sierra Bancorp announces new 630,000 share repurchase program 01/11/23 Franklin Resources reports December AUM of $1.39T vs. $1.41T m/m 12/13/22 Franklin Resources raises quarterly dividend by 3.4% to 30c per share 12/09/22 Franklin Resources Canada announces approval of changes for certain ETFs 11/09/22 Franklin Resources reports AUM of $1.3184T as of October 31, 2022 12/05/22 Axalta Coating enters multiyear agreement with Steer Automotive Group 11/16/22 Axalta Coating appoints Villavarayan as CEO, President, member of board 08/29/22 Axalta Coating appoints Bertsch to board of directors 08/29/22 Axalta Coating appoints Jan Bertsch to board of directors ARLP Alliance Resource Partners 01/30/23 Alliance Resource Partners says well positioned to achieve record year in 2023 01/30/23 Alliance Resource Partners increases unit repurchase program to $100M 01/27/23 Alliance Resource Partners increases distribution 40% to 70c per unit 12/08/22 Alliance Resource Partners names Cary P. Marshall as new CFO 11/28/22 Alpha Metallurgical sees FY23 total shipments 16.7M-18.4M tons 09/13/22 Alpha Metallurgical updates 2023 domestic sales commitments and share repurchase 08/08/22 Alpha Metallurgical increases quarterly dividend to 39.2c from 37.5c per share 08/08/22 Alpha Metallurgical provides 2022 operational guidance 01/09/23 Illumina, Nashville Biosciences announce sequencing agreement with Amgen 01/03/23 Researchers' reanalysis questions mortality data in FOURIER trial 12/13/22 Amgen announces presentation of results from E1910 randomized Phase 3 trial 12/12/22 Amgen raises quarterly dividend by 10% to $2.13 01/25/23 BofA General Electric price target raised to $92 from $85 at BofA 01/19/23 Redburn GE HealthCare initiated with a Buy at Redburn 01/09/23 BofA General Electric price target lowered to $85 from $105 at BofA 01/04/23 Edward Jones GE HealthCare initiated with a Hold at Edward Jones 01/25/23 JPMorgan Ford price target lowered to $15 from $16 at JPMorgan 01/11/23 Goldman Sachs Goldman continues to prefer Tesla and GM among automakers 12/21/22 Morgan Stanley Tesla shedding $600B of value presents buying opportunity, says Morgan Stanley 12/05/22 Jefferies Fox Factory price target raised to $135 from $120 at Jefferies 01/18/23 Citi ResMed upgraded to Buy at Citi as Philips CPAP recall drags on 01/17/23 Morgan Stanley Philips price target lowered to EUR 16 from EUR 17 at Morgan Stanley 01/17/23 UBS Philips downgraded to Sell from Neutral at UBS 01/10/23 Barclays Philips price target lowered to EUR 18.50 from EUR 19 at Barclays 01/30/23 Wedbush SoFi Technologies price target raised to $8 from $6 at Wedbush 01/17/23 JPMorgan SoFi Technologies initiated with a Neutral at JPMorgan 12/15/22 Piper Sandler SoFi Technologies price target lowered to $7.50 from $8.50 at Piper Sandler 11/28/22 BofA Student loan forbearance extension a near-term headwind for SoFi, says BofA ARLP Alliance Resource Partners 03/30/22 Noble Capital Alliance Resource Partners initiated with an Outperform at Noble Capital $166.72 / -11.14 (-6.26%)
01/30/23 Bernstein Bernstein sees orders as 'most critical' to Tesla stock 01/30/23 Berenberg Tesla upgraded to Buy from Hold at Berenberg 01/26/23 Morgan Stanley Tesla FY23 earnings could bottom near $3 per share, says Morgan Stanley 01/26/23 Wedbush Tesla price target raised to $200 from $175 at Wedbush 01/30/23 Cowen Regeneron upgraded at Cowen with Eylea 'secure' and pipeline 'delivering' 01/30/23 Cowen Regeneron upgraded to Outperform from Market Perform at Cowen 01/20/23 JPMorgan Regeneron upgraded to Overweight from Neutral at JPMorgan 01/09/23 Piper Sandler Piper 'at a loss' to explain Regeneron Q4 miss for Eylea 01/30/23 Stifel Okta upgraded to Buy from Hold at Stifel 01/24/23 JPMorgan Okta initiated with an Overweight at JPMorgan 01/23/23 Deutsche Bank Okta price target raised to $90 from $80 at Deutsche Bank 01/18/23 Scotiabank Okta initiated with an Outperform at Scotiabank 01/30/23 Craig-Hallum Craig-Hallum uncovers 'great buying opportunity' after Friday's confusion 01/30/23 Berenberg General Motors downgraded to Hold from Buy at Berenberg 01/25/23 JPMorgan General Motors price target lowered to $57 from $59 at JPMorgan 01/19/23 Deutsche Bank Deutsche Bank keeps Hold on General Motors, lowers price target to $33 01/30/23 Goldman Sachs Kohl's initiated with a Sell at Goldman Sachs 01/03/23 JPMorgan Kohl's price target lowered to $26 from $33 at JPMorgan 11/18/22 Gordon Haskett Ross Stores upgraded to Buy at Gordon Haskett as off-price starts to turn corner 11/09/22 Morgan Stanley Kohl's CEO departure 'unsurprising,' says Morgan Stanley 01/30/23 Goldman Sachs Macy's initiated with a Buy at Goldman Sachs 01/10/23 Guggenheim Guggenheim keeps Neutral rating on Macy's following Q4 update 01/10/23 Morgan Stanley Macy's assumed with an Equal Weight at Morgan Stanley 01/10/23 Deutsche Bank Macy's price target lowered to $22 from $23 at Deutsche Bank 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/03/23 Barclays Research raises 'valid questions' about Amgen's Repatha, says Barclays 12/13/22 BMO Capital Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital 12/13/22 Baird Amgen deal yields nice accretion but large debt position, says Baird 01/27/23 Deutsche Bank Southwest price target lowered to $52 from $56 at Deutsche Bank 01/27/23 Cowen Southwest price target lowered to $50 from $55 at Cowen 01/12/23 Barclays Southwest price target lowered to $42 from $48 at Barclays 01/11/23 Jefferies Delta Air Lines price target raised to $45 from $40 at Jefferies 01/25/23 Morgan Stanley Lucid Group price target lowered to $5 from $10 at Morgan Stanley 01/22/23 Citi Lucid Group resumed with a Buy at Citi 01/12/23 Cantor Fitzgerald Lucid's Q4 production pre-announcement 'encouraging, says Cantor Fitzgerald 01/12/23 Evercore ISI Evercore ISI says Lucid FY/Q4 production serves as glimmer of execution progress $139.13 / -1.135 (-0.81%)
01/24/23 BofA Banks' potential new online wallet unlikely to threaten PayPal, says BofA 01/17/23 Citi JPMorgan price target raised to $165 from $150 at Citi 01/17/23 Piper Sandler JPMorgan price target raised to $157 from $150 at Piper Sandler 01/06/23 Deutsche Bank JPMorgan downgraded to Hold with $145 target at Deutsche Bank 01/31/23 Barclays Colgate-Palmolive price target lowered to $77 from $80 at Barclays 01/30/23 Deutsche Bank Colgate-Palmolive price target lowered to $84 from $87 at Deutsche Bank 01/30/23 Morgan Stanley Colgate-Palmolive upgraded to Overweight from Equal Weight at Morgan Stanley 01/13/23 JPMorgan Colgate-Palmolive price target raised to $86 from $81 at JPMorgan 01/30/23 Fearnley Golden Ocean upgraded to Buy from Hold at Fearnley 09/26/22 Jefferies Golden Ocean downgraded to Hold from Buy at Jefferies 07/20/22 Jefferies Golden Ocean initiated with a Buy at Jefferies 05/20/22 Kepler Cheuvreux Golden Ocean downgraded to Hold from Buy at Kepler Cheuvreux 01/30/23 Barclays Axalta Coating price target raised to $33 from $30 at Barclays 01/30/23 Wells Fargo Axalta Coating price target raised to $29 from $23 at Wells Fargo 01/30/23 Deutsche Bank Axalta Coating upgraded to Buy from Hold at Deutsche Bank 01/30/23 Citi Axalta Coating upgraded to Buy from Neutral at Citi 01/27/23 BTIG BTIG sees Legend commercializing Carvykti in earlier lines after study hits goal 01/27/23 Piper Sandler Piper keeps $78 target on Legend Biotech after Carvykti trial hits 01/25/23 JMP Securities J&J conference call comments 'a good sign' for Protagonist, says JMP Securities 01/24/23 H.C. Wainwright Fate Therapeutics downgraded to Neutral from Buy at H.C. Wainwright 11/28/22 Berenberg Berenberg starts 'well-positioned' disruptor Ginkgo Bioworks with a Buy 11/28/22 Berenberg Ginkgo Bioworks initiated with a Buy at Berenberg 10/04/22 Morgan Stanley Ginkgo Bioworks initiated with an Equal Weight at Morgan Stanley 08/16/22 BTIG Ginkgo Bioworks price target raised to $6 from $5 at BTIG 12/14/22 Wells Fargo Wells Fargo starts Franklin Resources at Underweight on 'tough market' 12/14/22 Wells Fargo Franklin Resources initiated with an Underweight at Wells Fargo 11/15/22 Deutsche Bank Franklin Resources price target raised to $26 from $20 at Deutsche Bank 10/18/22 Credit Suisse Franklin Resources initiated with a Neutral at Credit Suisse 01/09/23 Credit Suisse Dynex Capital upgraded to Outperform from Neutral at Credit Suisse 01/03/23 BTIG Dynex Capital named Top Pick for first half of 2023 at BTIG 12/19/22 JonesResearch Dynex Capital price target raised to $14 from $13.50 at JonesTrading 10/24/22 BTIG Dynex Capital price target lowered to $13 from $17 at BTIG 11/13/22 Keefe Bruyette Sierra Bancorp downgraded to Market Perform from Outperform at Keefe Bruyette 07/07/22 Raymond James Sierra Bancorp downgraded to Market Perform from Outperform at Raymond James 07/07/22 Raymond James Sierra Bancorp downgraded to Market Perform from Outperform at Raymond James 01/17/23 B. Riley Alpha Metallurgical price target raised to $202 from $193 at B. Riley 01/17/23 B. Riley B. Riley downgrades trio of coal-linked stocks after updating price deck 11/08/22 B. Riley Alpha Metallurgical price target raised to $195 from $189 at B. Riley 11/08/22 Cowen Alpha Metallurgical price target lowered to $215 from $225 at Cowen 12/19/22 Alliance Global Partners Flora Growth price target lowered to $1.25 from $2 at Alliance Global Partners 10/24/22 Alliance Global Partners Flora Growth price target lowered to $2 from $2.50 at Alliance Global Partners 09/23/22 Alliance Global Partners Flora Growth initiated with a Buy at Alliance Global Partners 08/01/22 Cantor Fitzgerald Cantor starts Flora Growth with Neutral amid diversification process $166.72 / -11.14 (-6.26%)
01/25/23 Tesla reports Q4 EPS $1.19, consensus $1.13 01/25/23 Notable companies reporting after market close 10/19/22 Tesla reports Q3 EPS $1.05, consensus 99c 10/19/22 Notable companies reporting after market close 01/30/23 SoFi Technologies sees FY23 revenue $1.93B-$2B, consensus $2B 01/30/23 SoFi Technologies sees Q1 revenue $430M-$440M, consensus $445.82M 01/30/23 SoFi Technologies reports Q4 EPS (5c), consensus (9c) 11/01/22 SoFi Technologies reports Q3 EPS (9c), consensus (10c) 01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea 11/03/22 Regeneron reports Q3 EPS $11.14, consensus $9.48 11/02/22 Notable companies reporting before tomorrow's open 01/30/23 Philips reports Q4 adjusted EPS EUR 0.41 vs. EUR 0.57 last year 10/24/22 Philips reports Q3 adjusted EPS EUR 0.25 vs. EUR 0.40 last year 10/12/22 Philips sees Q3 group revenue EUR 4.3B 11/30/22 Okta raises FY23 EPS view to (27c)-(26c) from (73c)-(70c), consensus (72c) 11/30/22 Okta sees Q4 adjusted EPS 9c-10c, consensus (11c) 11/30/22 Okta reports Q3 adjusted EPS 0c, consensus (24c) 11/30/22 Notable companies reporting after market close 01/06/23 Macy's backs Q4 adjusted EPS view $1.47-$1.67, consensus $1.60 11/17/22 Macy's sees Q4 adjusted EPS $1.47-$1.67, consensus $1.83 11/17/22 Macy's sees Q4 net sales $8.16B-$8.4B, consensus $8.36B 11/17/22 Macy's raises FY22 adjusted EPS view to $4.07-$4.27 from $4.00-$4.20 01/26/23 Southwest sees Q1 revenue up 20%-24%, consensus $5.88B 01/26/23 Southwest reports Q4 adjusted EPS (38c), consensus (9c) 01/25/23 Notable companies reporting before tomorrow's open 11/08/22 Lucid Group reports Q3 EPS (40c), consensus (31c) 11/08/22 Notable companies reporting after market close 08/03/22 Lucid Group reports Q2 EPS (33c), consensus (36c) 08/03/22 Notable companies reporting after market close 11/17/22 Kohl's withdraws FY22 guidance 11/17/22 Kohl's reports Q3 adjusted EPS 82c, consensus 78c 11/16/22 Notable companies reporting before tomorrow's open $139.13 / -1.135 (-0.81%)
01/13/23 JPMorgan reports Q4 EPS $3.57, consensus $3.07 01/12/23 Notable companies reporting before tomorrow's open 10/14/22 JPMorgan reports Q3 EPS $3.12, consensus $2.88 01/30/23 Johnson & Johnson to challenge federal appeals court ruling 01/24/23 Johnson & Johnson sees FY23 adjusted EPS $10.45- $10.65, consensus $10.33 01/24/23 Johnson & Johnson sees FY23 adjusted operational EPS $10.40-$10.60 01/24/23 Johnson & Johnson sees FY23 adjusted operation EPS $10.50, consensus $10.33 08/25/22 Golden Ocean reports Q2 EPS 82c vs. 63c last year 01/30/23 Notable companies reporting before tomorrow's open 11/17/22 General Motors narrows FY22 EBIT-adjusted view to $13.5B-$14.5B from $13B-$15B 10/25/22 General Motors backs FY22 adjusted EPS view $6.50-$7.50, consensus $6.79 10/25/22 General Motors reports Q3 adjusted EPS $2.25, consensus $1.88 01/30/23 GE HealthCare sees FY23 adjusted EPS $3.60-$3.75 01/30/23 GE HealthCare reports Q4 adjusted EPS $1.31 vs. $1.36 a year ago 01/10/23 GE HealthCare sees FY23 organic revenue growth 5%-7% 01/10/23 GE HealthCare sees FY22 revenue about $18.3B 01/30/23 Flora Growth Sees FY23 revenue $90M-$105M, consensus $95.62M 11/28/22 Flora Growth backs FY22 revenue view $35M-$45M 11/28/22 Flora Growth reports Q3 EPS (10c) vs. (8c) last year 10/26/22 Ford reports Q3 adjusted EPS 39c, consensus 27c 10/26/22 Notable companies reporting after market close 01/30/23 Dynex Capital reports non-GAAP Q4 EPS 3c , consensus 20c 01/30/23 Dynex Capital reports Q4 EPS 85c, consensus 20c 10/24/22 Dynex Capital reports Q3 EPS 24c, consensus 32c 01/11/23 Ginkgo Bioworks backs FY22 revenue view $460M-$480M, consensus $470.79M 11/14/22 Ginkgo Bioworks sees FY22 revenue $425M-$440M, consensus $435.34M 11/14/22 Ginkgo Bioworks reports Q3 EPS (41c), consensus (30c) 08/15/22 Ginkgo Bioworks raises FY22 revenue view to $425M-$440M from $375M-$390M 01/27/23 Colgate-Palmolive sees 2023 net sales growth 2%-5%, consensus $18.61B 01/27/23 Colgate-Palmolive reports Q4 base EPS 77c, consensus 76c 01/26/23 Notable companies reporting before tomorrow's open 01/30/23 Sierra Bancorp reports Q4 EPS 47c, consensus 71c 10/24/22 Sierra Bancorp reports Q3 EPS 66c, consensus 67c 01/30/23 Franklin Resources reports Q1 EPS 51c, consensus 54c 11/01/22 Franklin Resources reports preliminary Q4 adjusted EPS 78c, consensus 67c 01/25/23 Axalta Coating sees Q1 adjusted EPS 26c-33c, consensus 33c 01/25/23 Axalta Coating reports Q4 adjusted EPS 38c, consensus 35c 10/25/22 Axalta Coating sees Q4 adjusted EPS 31c-39c, consensus 42c 10/25/22 Axalta Coating reports Q3 adjusted EPS 39c, consensus 39c ARLP Alliance Resource Partners 01/30/23 Alliance Resource Partners reports Q4 EPS $1.63, consensus $1.42 10/31/22 Alliance Resource Partners reports Q3 EPS $1.25, consensus $1.50 08/01/22 Alliance Resource Partners reports Q1 EPS $1.23, consensus 95c 01/30/23 Alpha Metallurgical sees Q4 EPS $13.37, consensus $18.14 11/07/22 Alpha Metallurgical reports Q3 EPS $14.21, consensus $16.81 08/08/22 Alpha Metallurgical reports Q2 EPS $30.03, consensus $30.8 11/03/22 Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00 11/03/22 Amgen reports Q3 adjusted EPS $4.70, consensus $4.44 11/03/22 Notable companies reporting after market close 08/04/22 Amgen backs FY22 adjusted EPS view $17.00-$18.00, consensus $17.40
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
01/25/23 Tesla extends afterhours gains, up over 5% at $152.45 01/25/23 Tesla CEO says Dojo AI to be competitive with Nvidia at end of 2023 01/25/23 Tesla CEO says we have other products in development 01/25/23 Tesla's Musk says probably will have 'difficult recession this year' 12/14/22 SoFi Technologies spikes over 8% after CEO Noto buys $5M in shares 12/13/22 SoFi Technologies CEO buys $5M in common stock 11/21/22 SoFi says cryptocurrency 'non-material component' of business 11/21/22 Sen. Brown, colleagues ask bank regulators to review SoFi's crypto activities 01/24/23 Rio Tinto trading resumes 01/24/23 Rio Tinto trading halted, volatility trading pause 01/17/23 Rio Tinto guides 2023 Pilbara iron ore shipments 320-335 Mt vs. 322 in 2022 01/17/23 Rio Tinto reports Q4 Pilbara iron ore production 89.5 Mt, up 6% y/y $737.85 / -7.155 (-0.96%)
01/30/23 Regeneron, Sanofi announce EC expansion of Dupixent marketing authorization 01/27/23 Regeneron, Sanofi announce CHMP opinion recommending EU approval for Dupixent 01/06/23 2seventy Bio announces amendment to collaboration with Regeneron 01/05/23 CytomX Therapeutics updates business, announces 2023 relationship with Moderna 01/30/23 Philips sees FY23 comparable sales up low-single-digits 01/30/23 Philips to reduce workforce by additional 3,000 roles in 2023, 6,000 by 2025 01/18/23 Masimo, Philips expands partnership to improve telehealth for patients 12/21/22 Philips gives update on test, research program of PE-PUR sound abatement foam 01/12/23 Okta says there will be some disruption from sales leadership changes 01/12/23 authID integrates Verified CloudConnect with Okta Workforce Identity Cloud 12/21/22 Okta says code repositories copied in early December GitHub hack 11/15/22 Okta debuts 'Okta for US Military' purpose-built identity environment for DoD 01/09/23 Macy's falls -9.0% 01/06/23 Macy's falls 4% to $21.23 after guiding Q4 sales to low-end to midpoint of range 11/17/22 Macy's rises 12.2% 11/17/22 Macy's rises 9.5% 01/26/23 Southwest says it continues to experience year-over-year inflationary pressures 01/26/23 Southwest plans to add 7,000 workers in 2023 01/26/23 Southwest sees FY23 economic fuel costs per gallon $2.90-$3.00 01/23/23 Southwest dispatch staff reaches tentative agreement on contract 11/14/22 Starboard takes stake in Wix.com, exits Elanco Animal Health 11/14/22 Appaloosa exits positions in Kohl's, Occidental Petroleum, Micron 11/08/22 Ancora supports management transition at Kohl's 11/08/22 Levi Strauss appoints Michelle Gass as President, to succeed Bergh as CEO 01/30/23 Johnson & Johnson falls after court rejects bankruptcy plan for talc lawsuits 01/30/23 J&J drops 3% after court rejects bankruptcy plan for talc lawsuits 01/27/23 Janssen announces unblinding of Phase 3 CARTITUDE-4 study of CARVYKTI 01/24/23 Johnson & Johnson says assuming a lot of inflationary carryover in 2023 10/04/22 Golden Ocean board authorizes $100M share buy-back program 01/30/23 GM Defense, American Rheinmetall win contract for U.S. Army's CTT Program 01/20/23 GM investing $918M in four U.S. facilities for V-8 engines, EV components 01/10/23 RMI launches virtual power plant partnership with GM, Google, Ford 01/23/23 GE HealthCare, Windsor Regional Hospital enter long-term MES agreement 01/09/23 GE HealthCare announces acquisition of CT firm Imactis, terms undisclosed 01/09/23 GE HealthCare to acquire IMACTIS, terms not disclosed 01/05/23 GE HealthCare names Taha Kass-Hout CTO 01/06/23 Flora Growth receives 180 day extension to regain compliance with Nasdaq 01/05/23 Flora Growth provides update on commercial cannabis operations in Colombia 11/14/22 Flora Growth partners with 357 Company to launch 357 Canna Logistics 10/24/22 Flora Growth to acquire medical cannabis Franchise Global Health 01/30/23 Ford to 'significantly increase' Mustang Mach-E production, cut prices 01/26/23 Ford expands complimentary pick-up & delivery mobile service nationwide 01/23/23 Ford sees Q4 pre-tax remeasurement gain of roughly $50M from pension, OPEB plans 01/18/23 EU passenger car registrations up 12.8% in December 08/24/22 Dynex Capital CFO buys $158.4K in common stock 01/18/23 Ginkgo Bioworks and NAMUH announce collaboration to develop HMOs 01/17/23 Ginkgo Bioworks, Xwell expand support for CDC's Genomic Surveillance program 01/17/23 Ginkgo Bioworks and Xwell partner in influenza variant detection for CDC 01/09/23 Ginkgo Bioworks, Prokarium announce RNA collaboration 01/30/23 Colgate-Palmolive names Steve Cahillane to Board of Directors 11/14/22 Third Point buys TJX, exits Cenovus Energy in Q3 10/28/22 Colgate-Palmolive CEO says negative impact from currency accelerated in Q3 10/28/22 Colgate-Palmolive reports Q3 gross profit margin 57.2%, down 220 bps 01/11/23 COPT forms two data center JVs with Blackstone Real Estate 01/03/23 UC Investments to invest $4B in Blackstone Real Estate Income Trust 01/03/23 Targa to acquire Blackstone's 25% interest in Grand Prix for $1.05B 12/12/22 Thomson Reuters, Blackstone to sell shares of LSEG to Microsoft 10/21/22 Sierra Bancorp announces new 630,000 share repurchase program 01/11/23 Franklin Resources reports December AUM of $1.39T vs. $1.41T m/m 12/13/22 Franklin Resources raises quarterly dividend by 3.4% to 30c per share 12/09/22 Franklin Resources Canada announces approval of changes for certain ETFs 11/09/22 Franklin Resources reports AUM of $1.3184T as of October 31, 2022 12/05/22 Axalta Coating enters multiyear agreement with Steer Automotive Group 11/16/22 Axalta Coating appoints Villavarayan as CEO, President, member of board 08/29/22 Axalta Coating appoints Bertsch to board of directors 08/29/22 Axalta Coating appoints Jan Bertsch to board of directors ARLP Alliance Resource Partners 01/30/23 Alliance Resource Partners says well positioned to achieve record year in 2023 01/30/23 Alliance Resource Partners increases unit repurchase program to $100M 01/27/23 Alliance Resource Partners increases distribution 40% to 70c per unit 12/08/22 Alliance Resource Partners names Cary P. Marshall as new CFO 11/28/22 Alpha Metallurgical sees FY23 total shipments 16.7M-18.4M tons 09/13/22 Alpha Metallurgical updates 2023 domestic sales commitments and share repurchase 08/08/22 Alpha Metallurgical increases quarterly dividend to 39.2c from 37.5c per share 08/08/22 Alpha Metallurgical provides 2022 operational guidance 01/09/23 Illumina, Nashville Biosciences announce sequencing agreement with Amgen 01/03/23 Researchers' reanalysis questions mortality data in FOURIER trial 12/13/22 Amgen announces presentation of results from E1910 randomized Phase 3 trial 12/12/22 Amgen raises quarterly dividend by 10% to $2.13 01/25/23 BofA General Electric price target raised to $92 from $85 at BofA 01/19/23 Redburn GE HealthCare initiated with a Buy at Redburn 01/09/23 BofA General Electric price target lowered to $85 from $105 at BofA 01/04/23 Edward Jones GE HealthCare initiated with a Hold at Edward Jones 01/25/23 JPMorgan Ford price target lowered to $15 from $16 at JPMorgan 01/11/23 Goldman Sachs Goldman continues to prefer Tesla and GM among automakers 12/21/22 Morgan Stanley Tesla shedding $600B of value presents buying opportunity, says Morgan Stanley 12/05/22 Jefferies Fox Factory price target raised to $135 from $120 at Jefferies 01/18/23 Citi ResMed upgraded to Buy at Citi as Philips CPAP recall drags on 01/17/23 Morgan Stanley Philips price target lowered to EUR 16 from EUR 17 at Morgan Stanley 01/17/23 UBS Philips downgraded to Sell from Neutral at UBS 01/10/23 Barclays Philips price target lowered to EUR 18.50 from EUR 19 at Barclays 01/17/23 JPMorgan SoFi Technologies initiated with a Neutral at JPMorgan 12/15/22 Piper Sandler SoFi Technologies price target lowered to $7.50 from $8.50 at Piper Sandler 11/28/22 BofA Student loan forbearance extension a near-term headwind for SoFi, says BofA 11/23/22 Mizuho SoFi Technologies price target lowered to $6 from $7 at Mizuho ARLP Alliance Resource Partners 03/30/22 Noble Capital Alliance Resource Partners initiated with an Outperform at Noble Capital 01/30/23 Bernstein Bernstein sees orders as 'most critical' to Tesla stock 01/30/23 Berenberg Tesla upgraded to Buy from Hold at Berenberg 01/26/23 Morgan Stanley Tesla FY23 earnings could bottom near $3 per share, says Morgan Stanley 01/26/23 Wedbush Tesla price target raised to $200 from $175 at Wedbush 01/30/23 Craig-Hallum Craig-Hallum uncovers 'great buying opportunity' after Friday's confusion 01/30/23 Berenberg General Motors downgraded to Hold from Buy at Berenberg 01/25/23 JPMorgan General Motors price target lowered to $57 from $59 at JPMorgan 01/19/23 Deutsche Bank Deutsche Bank keeps Hold on General Motors, lowers price target to $33 $737.85 / -7.155 (-0.96%)
01/30/23 Cowen Regeneron upgraded at Cowen with Eylea 'secure' and pipeline 'delivering' 01/30/23 Cowen Regeneron upgraded to Outperform from Market Perform at Cowen 01/20/23 JPMorgan Regeneron upgraded to Overweight from Neutral at JPMorgan 01/09/23 Piper Sandler Piper 'at a loss' to explain Regeneron Q4 miss for Eylea 01/30/23 Stifel Okta upgraded to Buy from Hold at Stifel 01/24/23 JPMorgan Okta initiated with an Overweight at JPMorgan 01/23/23 Deutsche Bank Okta price target raised to $90 from $80 at Deutsche Bank 01/18/23 Scotiabank Okta initiated with an Outperform at Scotiabank 01/30/23 Goldman Sachs Macy's initiated with a Buy at Goldman Sachs 01/10/23 Guggenheim Guggenheim keeps Neutral rating on Macy's following Q4 update 01/10/23 Morgan Stanley Macy's assumed with an Equal Weight at Morgan Stanley 01/10/23 Deutsche Bank Macy's price target lowered to $22 from $23 at Deutsche Bank 01/30/23 Goldman Sachs Kohl's initiated with a Sell at Goldman Sachs 01/03/23 JPMorgan Kohl's price target lowered to $26 from $33 at JPMorgan 11/18/22 Gordon Haskett Ross Stores upgraded to Buy at Gordon Haskett as off-price starts to turn corner 11/09/22 Morgan Stanley Kohl's CEO departure 'unsurprising,' says Morgan Stanley 01/19/23 Piper Sandler Amgen price target cut at Piper on lower Otezla estimates 01/03/23 Barclays Research raises 'valid questions' about Amgen's Repatha, says Barclays 12/13/22 BMO Capital Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital 12/13/22 Baird Amgen deal yields nice accretion but large debt position, says Baird 01/27/23 Deutsche Bank Southwest price target lowered to $52 from $56 at Deutsche Bank 01/27/23 Cowen Southwest price target lowered to $50 from $55 at Cowen 01/12/23 Barclays Southwest price target lowered to $42 from $48 at Barclays 01/11/23 Jefferies Delta Air Lines price target raised to $45 from $40 at Jefferies 01/27/23 BMO Capital Blackstone price target raised to $92 from $85 at BMO Capital 01/27/23 Barclays Blackstone price target raised to $100 from $86 at Barclays 01/24/23 JPMorgan TPG downgraded to Neutral from Overweight at JPMorgan 01/24/23 JPMorgan Blackstone upgraded to Overweight from Neutral at JPMorgan 01/23/23 Morgan Stanley Rio Tinto price target raised to 5,790 GBp from 5,750 GBp at Morgan Stanley 01/18/23 JPMorgan Rio Tinto price target raised to 5,380 GBp from 5,310 GBp at JPMorgan 01/17/23 CLSA Rio Tinto downgraded to Underperform from Outperform at CLSA 01/12/23 Barclays Rio Tinto upgraded to Equal Weight from Underweight at Barclays 01/30/23 Deutsche Bank Colgate-Palmolive price target lowered to $84 from $87 at Deutsche Bank 01/30/23 Morgan Stanley Colgate-Palmolive upgraded to Overweight from Equal Weight at Morgan Stanley 01/13/23 JPMorgan Colgate-Palmolive price target raised to $86 from $81 at JPMorgan 12/06/22 Deutsche Bank Colgate-Palmolive price target raised to $87 from $85 at Deutsche Bank 01/30/23 Fearnley Golden Ocean upgraded to Buy from Hold at Fearnley 09/26/22 Jefferies Golden Ocean downgraded to Hold from Buy at Jefferies 07/20/22 Jefferies Golden Ocean initiated with a Buy at Jefferies 05/20/22 Kepler Cheuvreux Golden Ocean downgraded to Hold from Buy at Kepler Cheuvreux 01/30/23 Barclays Axalta Coating price target raised to $33 from $30 at Barclays 01/30/23 Wells Fargo Axalta Coating price target raised to $29 from $23 at Wells Fargo 01/30/23 Deutsche Bank Axalta Coating upgraded to Buy from Hold at Deutsche Bank 01/30/23 Citi Axalta Coating upgraded to Buy from Neutral at Citi 11/28/22 Berenberg Berenberg starts 'well-positioned' disruptor Ginkgo Bioworks with a Buy 11/28/22 Berenberg Ginkgo Bioworks initiated with a Buy at Berenberg 10/04/22 Morgan Stanley Ginkgo Bioworks initiated with an Equal Weight at Morgan Stanley 08/16/22 BTIG Ginkgo Bioworks price target raised to $6 from $5 at BTIG 12/14/22 Wells Fargo Wells Fargo starts Franklin Resources at Underweight on 'tough market' 12/14/22 Wells Fargo Franklin Resources initiated with an Underweight at Wells Fargo 11/15/22 Deutsche Bank Franklin Resources price target raised to $26 from $20 at Deutsche Bank 10/18/22 Credit Suisse Franklin Resources initiated with a Neutral at Credit Suisse 01/09/23 Credit Suisse Dynex Capital upgraded to Outperform from Neutral at Credit Suisse 01/03/23 BTIG Dynex Capital named Top Pick for first half of 2023 at BTIG 12/19/22 JonesResearch Dynex Capital price target raised to $14 from $13.50 at JonesTrading 10/24/22 BTIG Dynex Capital price target lowered to $13 from $17 at BTIG 11/13/22 Keefe Bruyette Sierra Bancorp downgraded to Market Perform from Outperform at Keefe Bruyette 07/07/22 Raymond James Sierra Bancorp downgraded to Market Perform from Outperform at Raymond James 07/07/22 Raymond James Sierra Bancorp downgraded to Market Perform from Outperform at Raymond James 01/17/23 B. Riley Alpha Metallurgical price target raised to $202 from $193 at B. Riley 01/17/23 B. Riley B. Riley downgrades trio of coal-linked stocks after updating price deck 11/08/22 B. Riley Alpha Metallurgical price target raised to $195 from $189 at B. Riley 11/08/22 Cowen Alpha Metallurgical price target lowered to $215 from $225 at Cowen 12/19/22 Alliance Global Partners Flora Growth price target lowered to $1.25 from $2 at Alliance Global Partners 10/24/22 Alliance Global Partners Flora Growth price target lowered to $2 from $2.50 at Alliance Global Partners 09/23/22 Alliance Global Partners Flora Growth initiated with a Buy at Alliance Global Partners 08/01/22 Cantor Fitzgerald Cantor starts Flora Growth with Neutral amid diversification process 01/27/23 BTIG BTIG sees Legend commercializing Carvykti in earlier lines after study hits goal 01/27/23 Piper Sandler Piper keeps $78 target on Legend Biotech after Carvykti trial hits 01/25/23 JMP Securities J&J conference call comments 'a good sign' for Protagonist, says JMP Securities 01/24/23 H.C. Wainwright Fate Therapeutics downgraded to Neutral from Buy at H.C. Wainwright 01/25/23 Tesla reports Q4 EPS $1.19, consensus $1.13 01/25/23 Notable companies reporting after market close 10/19/22 Tesla reports Q3 EPS $1.05, consensus 99c 10/19/22 Notable companies reporting after market close 01/30/23 SoFi Technologies sees FY23 revenue $1.93B-$2B, consensus $2B 01/30/23 SoFi Technologies sees Q1 revenue $430M-$440M, consensus $445.82M 01/30/23 SoFi Technologies reports Q4 EPS (5c), consensus (9c) 11/01/22 SoFi Technologies reports Q3 EPS (9c), consensus (10c) $737.85 / -7.155 (-0.96%)
01/09/23 Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea 11/03/22 Regeneron reports Q3 EPS $11.14, consensus $9.48 11/02/22 Notable companies reporting before tomorrow's open 01/30/23 Philips reports Q4 adjusted EPS EUR 0.41 vs. EUR 0.57 last year 10/24/22 Philips reports Q3 adjusted EPS EUR 0.25 vs. EUR 0.40 last year 10/12/22 Philips sees Q3 group revenue EUR 4.3B 11/30/22 Okta raises FY23 EPS view to (27c)-(26c) from (73c)-(70c), consensus (72c) 11/30/22 Okta sees Q4 adjusted EPS 9c-10c, consensus (11c) 11/30/22 Okta reports Q3 adjusted EPS 0c, consensus (24c) 11/30/22 Notable companies reporting after market close 01/06/23 Macy's backs Q4 adjusted EPS view $1.47-$1.67, consensus $1.60 11/17/22 Macy's sees Q4 adjusted EPS $1.47-$1.67, consensus $1.83 11/17/22 Macy's sees Q4 net sales $8.16B-$8.4B, consensus $8.36B 11/17/22 Macy's raises FY22 adjusted EPS view to $4.07-$4.27 from $4.00-$4.20 01/26/23 Southwest sees Q1 revenue up 20%-24%, consensus $5.88B 01/26/23 Southwest reports Q4 adjusted EPS (38c), consensus (9c) 01/25/23 Notable companies reporting before tomorrow's open 11/17/22 Kohl's withdraws FY22 guidance 11/17/22 Kohl's reports Q3 adjusted EPS 82c, consensus 78c 11/16/22 Notable companies reporting before tomorrow's open 01/24/23 Johnson & Johnson sees FY23 adjusted EPS $10.45- $10.65, consensus $10.33 01/24/23 Johnson & Johnson sees FY23 adjusted operational EPS $10.40-$10.60 01/24/23 Johnson & Johnson sees FY23 adjusted operation EPS $10.50, consensus $10.33 01/24/23 Johnson & Johnson reports Q4 adjusted EPS $2.35, consensus $2.23 08/25/22 Golden Ocean reports Q2 EPS 82c vs. 63c last year 11/17/22 General Motors narrows FY22 EBIT-adjusted view to $13.5B-$14.5B from $13B-$15B 10/25/22 General Motors backs FY22 adjusted EPS view $6.50-$7.50, consensus $6.79 10/25/22 General Motors reports Q3 adjusted EPS $2.25, consensus $1.88 10/24/22 Notable companies reporting before tomorrow's open 01/30/23 GE HealthCare sees FY23 adjusted EPS $3.60-$3.75 01/30/23 GE HealthCare reports Q4 adjusted EPS $1.31 vs. $1.36 a year ago 01/10/23 GE HealthCare sees FY23 organic revenue growth 5%-7% 01/10/23 GE HealthCare sees FY22 revenue about $18.3B 01/30/23 Flora Growth Sees FY23 revenue $90M-$105M, consensus $95.62M 11/28/22 Flora Growth backs FY22 revenue view $35M-$45M 11/28/22 Flora Growth reports Q3 EPS (10c) vs. (8c) last year 10/26/22 Ford reports Q3 adjusted EPS 39c, consensus 27c 10/26/22 Notable companies reporting after market close 01/30/23 Dynex Capital reports non-GAAP Q4 EPS 3c , consensus 20c 01/30/23 Dynex Capital reports Q4 EPS 85c, consensus 20c 10/24/22 Dynex Capital reports Q3 EPS 24c, consensus 32c 01/11/23 Ginkgo Bioworks backs FY22 revenue view $460M-$480M, consensus $470.79M 11/14/22 Ginkgo Bioworks sees FY22 revenue $425M-$440M, consensus $435.34M 11/14/22 Ginkgo Bioworks reports Q3 EPS (41c), consensus (30c) 08/15/22 Ginkgo Bioworks raises FY22 revenue view to $425M-$440M from $375M-$390M 01/27/23 Colgate-Palmolive sees 2023 net sales growth 2%-5%, consensus $18.61B 01/27/23 Colgate-Palmolive reports Q4 base EPS 77c, consensus 76c 01/26/23 Notable companies reporting before tomorrow's open 01/27/23 Blackstone reports Q4 distributable EPS $1.07 vs. $1.71 y/y 01/25/23 UC Investments to invest additional $500M in BREIT common shares 01/30/23 Sierra Bancorp reports Q4 EPS 47c, consensus 71c 10/24/22 Sierra Bancorp reports Q3 EPS 66c, consensus 67c 01/30/23 Franklin Resources reports Q1 EPS 51c, consensus 54c 11/01/22 Franklin Resources reports preliminary Q4 adjusted EPS 78c, consensus 67c 01/25/23 Axalta Coating sees Q1 adjusted EPS 26c-33c, consensus 33c 01/25/23 Axalta Coating reports Q4 adjusted EPS 38c, consensus 35c 10/25/22 Axalta Coating sees Q4 adjusted EPS 31c-39c, consensus 42c 10/25/22 Axalta Coating reports Q3 adjusted EPS 39c, consensus 39c ARLP Alliance Resource Partners 01/30/23 Alliance Resource Partners reports Q4 EPS $1.63, consensus $1.42 10/31/22 Alliance Resource Partners reports Q3 EPS $1.25, consensus $1.50 08/01/22 Alliance Resource Partners reports Q1 EPS $1.23, consensus 95c 01/30/23 Alpha Metallurgical sees Q4 EPS $13.37, consensus $18.14 11/07/22 Alpha Metallurgical reports Q3 EPS $14.21, consensus $16.81 08/08/22 Alpha Metallurgical reports Q2 EPS $30.03, consensus $30.8 11/03/22 Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00 11/03/22 Amgen reports Q3 adjusted EPS $4.70, consensus $4.44 11/03/22 Notable companies reporting after market close 08/04/22 Amgen backs FY22 adjusted EPS view $17.00-$18.00, consensus $17.40
Over a week ago
Syndicate
Show Hide Related Items >> <<
01/18/23 Ginkgo Bioworks and NAMUH announce collaboration to develop HMOs 01/17/23 Ginkgo Bioworks, Xwell expand support for CDC's Genomic Surveillance program 01/17/23 Ginkgo Bioworks and Xwell partner in influenza variant detection for CDC 01/09/23 Ginkgo Bioworks, Prokarium announce RNA collaboration 11/28/22 Berenberg Berenberg starts 'well-positioned' disruptor Ginkgo Bioworks with a Buy 11/28/22 Berenberg Ginkgo Bioworks initiated with a Buy at Berenberg 10/04/22 Morgan Stanley Ginkgo Bioworks initiated with an Equal Weight at Morgan Stanley 08/16/22 BTIG Ginkgo Bioworks price target raised to $6 from $5 at BTIG 01/11/23 Ginkgo Bioworks backs FY22 revenue view $460M-$480M, consensus $470.79M 11/14/22 Ginkgo Bioworks sees FY22 revenue $425M-$440M, consensus $435.34M 11/14/22 Ginkgo Bioworks reports Q3 EPS (41c), consensus (30c) 08/15/22 Ginkgo Bioworks raises FY22 revenue view to $425M-$440M from $375M-$390M
On The Fly
Show Hide Related Items >> <<
01/19/23 Synlogic's SYNB1934 granted Rare Pediatric Disease Designation by FDA 12/15/22 Synlogic's SYNB8802 achieves proof of concept in enteric hyperoxaluria 10/18/22 Synlogic announces positive Phase 2 results for phenylketonuria candidate 09/06/22 Synlogic receives milestone payment und research collaboration with Roche SLRX Salarius Pharmaceuticals 01/19/23 Salarius Pharmaceuticals to present SP-3164 preclinical data 01/05/23 Salarius Pharmaceuticals announces issuance of new U.S. patent 12/13/22 Salarius Pharmaceuticals presents clinical data on seclidemstat 12/13/22 Salarius Pharmaceuticals presents SP-3164 data 01/19/23 Roche says Phase 3 IMbrave050 study of Tecentriq-Avastin met primary endpoint 01/12/23 Roche announces EC approval of Xofluza in children aged one year and above 01/09/23 Sonnet BioTherapeutics, Roche collaborate for SON-1010 with atezolizumab 01/06/23 Genentech announces FDA acceptance of, grants priority review for glofitamab BLA 01/20/23 Eli Lilly, Boehringer: FDA accepts sNDA for Jardiance for adults with CKD 01/19/23 Eli Lilly discloses FDA complete response letter for submission of donanemab 01/12/23 California AG files suit against drugmakers, PBMs over insulin prices 01/04/23 Altimmune appoints Jordt as Chief Business Officer 01/18/23 Ginkgo Bioworks and NAMUH announce collaboration to develop HMOs 01/17/23 Ginkgo Bioworks, Xwell expand support for CDC's Genomic Surveillance program 01/17/23 Ginkgo Bioworks and Xwell partner in influenza variant detection for CDC 01/09/23 Ginkgo Bioworks, Prokarium announce RNA collaboration CNCE Concert Pharmaceuticals 01/19/23 Sun to acquire Concert for $8 per share of stock in cash 11/21/22 Concert Pharmaceuticals presents data from THRIVE-AA1 study 09/10/22 Concert announces presentation of CTP-543 THRIVE-AA1 Phase 3 data 08/01/22 Concert Pharma reports results for 2nd CTP-543 Phase 3 trial in Alopecia Areata 01/09/23 BeyondSpring regains Nasdaq minimum bid price compliance 12/13/22 BeyondSpring presents plinabulin data in DIN in NSCLC patients 11/23/22 BeyondSpring receives minimum bid price requirement notice from Nasdaq 09/13/22 BeyondSpring presents new data on plinabulin CNCE Concert Pharmaceuticals 01/20/23 JonesResearch Concert Pharmaceuticals downgraded to Hold from Buy at JonesResearch 01/19/23 Jefferies Concert Pharmaceuticals downgraded to Hold from Buy at Jefferies 01/19/23 JMP Securities Concert Pharmaceuticals downgraded to Market Perform at JMP Securities 01/19/23 Truist Concert Pharmaceuticals downgraded to Hold from Buy at Truist SLRX Salarius Pharmaceuticals 03/11/22 H.C. Wainwright Salarius Pharmaceuticals price target lowered to $4 from $5 at H.C. Wainwright BLCM Bellicum Pharmaceuticals 02/16/22 Ladenburg Bellicum Pharmaceuticals initiated with a Buy at Ladenburg 11/11/22 Chardan Synlogic price target lowered to $7 from $9 at Chardan 10/18/22 Chardan Synlogic's topline data validates synthetic biotic design platform, says Chardan 10/18/22 Oppenheimer Synlogic price target raised to $8 from $6 at Oppenheimer 05/12/22 Oppenheimer Synlogic price target lowered to $6 from $7 at Oppenheimer 01/18/23 Deutsche Bank Deutsche Bank bearish on Roche heading into FY23, cuts to Sell 01/18/23 Deutsche Bank Roche downgraded to Sell from Hold at Deutsche Bank 01/12/23 Guggenheim Arvinas downgraded to Neutral at Guggenheim on rising ARV-471 risks 01/05/23 Jefferies Roche downgraded on 'tougher 2023 catalyst path' at Jefferies 11/28/22 Berenberg Berenberg starts 'well-positioned' disruptor Ginkgo Bioworks with a Buy 11/28/22 Berenberg Ginkgo Bioworks initiated with a Buy at Berenberg 10/04/22 Morgan Stanley Ginkgo Bioworks initiated with an Equal Weight at Morgan Stanley 08/16/22 BTIG Ginkgo Bioworks price target raised to $6 from $5 at BTIG 01/20/23 William Blair Donanemab CRL a 'positive headline' for Biogen's Leqembi, says William Blair 01/03/23 Barclays Eli Lilly price target raised to $400 from $395 at Barclays 12/23/22 Raymond James ProQR Therapeutics price target raised to $5 from $2 at Raymond James 11/10/22 Synlogic reports Q3 EPS (25c), consensus (23c) 08/11/22 Synlogic reports Q2 EPS (22c), consensus (23c) SLRX Salarius Pharmaceuticals 11/10/22 Salarius Pharmaceuticals reports Q3 EPS ($6.41) vs ($2.09) last year 08/08/22 Salarius Pharmaceuticals reports Q2 EPS (9c) vs (7c) last year 10/18/22 Roche reports nine months group sales CHF 47.04B vs. CHF 46.68B last year 12/13/22 Eli Lilly sees FY23 EPS $8.10-$8.30, consensus $9.15 12/13/22 Eli Lilly backs FY22 EPS view $7.70-$7.85, consensus $7.78 11/01/22 Eli Lilly cuts FY22 EPS view to $7.70-$7.85 from $7.90-$8.05, consensus $7.99 11/01/22 Eli Lilly reports Q3 EPS $1.98, consensus $1.96 01/11/23 Ginkgo Bioworks backs FY22 revenue view $460M-$480M, consensus $470.79M 11/14/22 Ginkgo Bioworks sees FY22 revenue $425M-$440M, consensus $435.34M 11/14/22 Ginkgo Bioworks reports Q3 EPS (41c), consensus (30c) 08/15/22 Ginkgo Bioworks raises FY22 revenue view to $425M-$440M from $375M-$390M CNCE Concert Pharmaceuticals 11/07/22 Concert Pharmaceuticals reports Q3 EPS (58c), consensus (59c) 08/04/22 Concert Pharmaceuticals reports Q2 EPS (59c), consensus (85c)
Hot Stocks
NAMUH, an infant…
NAMUH, an infant nutrition company, and Ginkgo Bioworks announced a multi-product collaboration to develop functional oligosaccharides that are structurally identical to those found in human breast milk. Human Milk Oligosaccharides, or HMOs, are essential fiber-like nutrients unique to human milk that provide an important energy source to beneficial gut bacteria in infants. Despite being the third most abundant component in human milk, HMOs are currently a small component in infant formulas, if present at all. Currently, NAMUH's proprietary technology provides for a cost-effective source of a family of HMOs via yeast fermentation.
Show Hide Related Items >> <<
01/17/23 Ginkgo Bioworks, Xwell expand support for CDC's Genomic Surveillance program 01/17/23 Ginkgo Bioworks and Xwell partner in influenza variant detection for CDC 01/09/23 Ginkgo Bioworks, Prokarium announce RNA collaboration 01/06/23 Ginkgo Bioworks expands R&D facilities 11/28/22 Berenberg Berenberg starts 'well-positioned' disruptor Ginkgo Bioworks with a Buy 11/28/22 Berenberg Ginkgo Bioworks initiated with a Buy at Berenberg 10/04/22 Morgan Stanley Ginkgo Bioworks initiated with an Equal Weight at Morgan Stanley 08/16/22 BTIG Ginkgo Bioworks price target raised to $6 from $5 at BTIG 01/11/23 Ginkgo Bioworks backs FY22 revenue view $460M-$480M, consensus $470.79M 11/14/22 Ginkgo Bioworks sees FY22 revenue $425M-$440M, consensus $435.34M 11/14/22 Ginkgo Bioworks reports Q3 EPS (41c), consensus (30c) 08/15/22 Ginkgo Bioworks raises FY22 revenue view to $425M-$440M from $375M-$390M
Hot Stocks
Ginkgo Bioworks (DNA) and…
Ginkgo Bioworks (DNA) and XWELL (XWEL) announced that they have expanded their support for the Centers for Disease Control and Prevention's Traveler-based Genomic Surveillance program to include a pilot study monitoring influenza viruses in addition to SARS-CoV-2. The partners continue to grow the program's capabilities to provide an additional source of viral surveillance to inform the selection of influenza vaccine viruses for the forthcoming 2023-2024 flu season.Since August 2021, the program, which is also being used to conduct surveillance for SARS-CoV-2, has delivered timely public health insights into rare and emerging SARS-CoV-2 variants and sublineages and informed responses to outbreaks and surges through an innovative public-private partnership between CDC, Concentric by Ginkgo, the biosecurity and public health unit of Ginkgo Bioworks, and XpresCheck by XWELL, Inc., a leading provider of SARS-CoV-2 testing in U.S. airports. Recognizing the high level of seasonal influenza activity this fall and winter, the program is leveraging its large-scale travel biosecurity platform to monitor influenza A and B viruses among arriving international travelers at selected U.S. airports.
Show Hide Related Items >> <<
12/12/22 Xwell expects to generate $25M in incremental revenue by 2025 12/05/22 Xwell to introduce customizable services in XpresSpa and Treat locations 11/09/22 Xwell announces planned opening of five new XpresSpa locations in IST 01/17/23 Ginkgo Bioworks and Xwell partner in influenza variant detection for CDC 01/09/23 Ginkgo Bioworks, Prokarium announce RNA collaboration 01/06/23 Ginkgo Bioworks expands R&D facilities 01/05/23 Cathie Wood's ARK Investment bought 1.16M shares of Ginkgo Bioworks today 11/28/22 Berenberg Berenberg starts 'well-positioned' disruptor Ginkgo Bioworks with a Buy 11/28/22 Berenberg Ginkgo Bioworks initiated with a Buy at Berenberg 10/04/22 Morgan Stanley Ginkgo Bioworks initiated with an Equal Weight at Morgan Stanley 08/16/22 BTIG Ginkgo Bioworks price target raised to $6 from $5 at BTIG 01/11/23 Ginkgo Bioworks backs FY22 revenue view $460M-$480M, consensus $470.79M 11/14/22 Ginkgo Bioworks sees FY22 revenue $425M-$440M, consensus $435.34M 11/14/22 Ginkgo Bioworks reports Q3 EPS (41c), consensus (30c) 08/15/22 Ginkgo Bioworks raises FY22 revenue view to $425M-$440M from $375M-$390M
Hot Stocks
Ginkgo Bioworks (DNA) and…
Ginkgo Bioworks (DNA) and Xwell (XWEL) have expanded their support for the Centers for Disease Control and Prevention's - CDC's - Traveler-based Genomic Surveillance program to include a pilot study monitoring influenza viruses in addition to SARS-CoV-2. The partners continue to grow the program's capabilities to provide an additional source of viral surveillance to inform the selection of influenza vaccine viruses for the forthcoming 2023-2024 flu season. Since August 2021, the program, which is also being used to conduct surveillance for SARS-CoV-2, has delivered public health insights into rare and emerging SARS-CoV-2 variants and sublineages and informed responses to outbreaks and surges through a public-private partnership between CDC, Concentric by Ginkgo, the biosecurity and public health unit of Ginkgo Bioworks, and XpresCheck by Xwell, a provider of SARS-CoV-2 testing in U.S. airports.
Show Hide Related Items >> <<
12/12/22 Xwell expects to generate $25M in incremental revenue by 2025 12/05/22 Xwell to introduce customizable services in XpresSpa and Treat locations 11/09/22 Xwell announces planned opening of five new XpresSpa locations in IST 11/07/22 Xwell enter partnership with Clockwork, bring robotic manicure to U.S. airports 01/09/23 Ginkgo Bioworks, Prokarium announce RNA collaboration 01/06/23 Ginkgo Bioworks expands R&D facilities 01/05/23 Cathie Wood's ARK Investment bought 1.16M shares of Ginkgo Bioworks today 01/05/23 Ginkgo Bioworks, Esperovax announce partnership to develop circular RNAs 11/28/22 Berenberg Berenberg starts 'well-positioned' disruptor Ginkgo Bioworks with a Buy 11/28/22 Berenberg Ginkgo Bioworks initiated with a Buy at Berenberg 10/04/22 Morgan Stanley Ginkgo Bioworks initiated with an Equal Weight at Morgan Stanley 08/16/22 BTIG Ginkgo Bioworks price target raised to $6 from $5 at BTIG 01/11/23 Ginkgo Bioworks backs FY22 revenue view $460M-$480M, consensus $470.79M 11/14/22 Ginkgo Bioworks sees FY22 revenue $425M-$440M, consensus $435.34M 11/14/22 Ginkgo Bioworks reports Q3 EPS (41c), consensus (30c) 08/15/22 Ginkgo Bioworks raises FY22 revenue view to $425M-$440M from $375M-$390M
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
01/10/23 WWE board elects Vince McMahon Executive Chairman of the Board 01/10/23 WWE co-CEO Stephanie McMahon announces resignation 01/09/23 WWE announces WrestleMania in Los Angeles breaks all-time gate record 01/06/23 WWE rises 22.2% 01/10/23 Wells Fargo exits Correspondent business, to reduce size of Servicing portfolio 01/03/23 Federal regulators issue joint statement on crypto-asset risks to banks 12/20/22 Wells Fargo to pay $1.7B in CFPB settlement, expects $3.5B in operating losses 12/20/22 Wells Fargo ordered to pay $3.7B by CFPB for mismanagement of auto loans WBD Warner Bros. Discovery 01/03/23 Warner Bros. Discovery enters audience measurement agreement with VideoAmp 01/02/23 Fly Intel: Top five weekend stock stories 12/14/22 Warner Bros.' game 'Hogwarts Legacy' to launch on Switch July 25, 2023 12/06/22 Warner Bros. Discovery, Amazon.com: HBO Max available on Prime Video in U.S. 01/11/23 Victoria's Secret approves $250M new share repurchase program 01/05/23 Victoria's Secret falls -9.1% 01/03/23 Victoria's Secret says Hauk resigns as Brand CEO 11/14/22 Greenlight takes new stake in Intel, exits position in Atlas Air 01/11/23 Ubisoft unveils revenue growth measures, cancels three unannounced projects 12/20/22 Ubisoft games bought on Stadia to transfer to Ubisoft Connect at no extra cost 11/16/22 Ubisoft, Riot partner to tackle harmful content in game chats 11/14/22 U.S. game content spending grew 2% y/y in October, says NPD 12/29/22 Mesa Air finalizes capacity agreement with United Airlines 01/10/23 Cathie Wood's ARK Investment bought 101K shares of Tesla today 01/09/23 Cathie Wood's ARK Investment bought 27.8K shares of Tesla today 01/08/23 Fly Intel: Top five weekend stock stories 01/04/23 Cathie Wood's ARK Investment bought 21K shares of Tesla today 12/13/22 Tandem Diabetes to acquire AMF Medical 11/10/22 Tandem Diabetes t:slim X2 care study demonstrates improvement in all endpoints 09/08/22 Tandem Diabetes CFO says 'goal is always to beat' guidance 09/08/22 Tandem Diabetes CEO saw 'positive shift,' start of 'momentum build' in August 01/11/23 Stem falls -6.0% 01/11/23 Blue Orca short Stem, says 'has all landmarks of failed SPAC' 01/11/23 Stem down 7% after Blue Orca makes accusations in short report 01/10/23 Stem rises 9.1% 01/11/23 FAA says 'ground stop has been lifted' 01/11/23 FAA 'making progress' in restoring NOAM system following outage 01/11/23 U.S. flights disrupted amid outage of FAA pilot advisory system 11/20/22 Fly Intel: Top five weekend stock stories 12/01/22 Nexstar to replace Sabre in the S&P 400 at open on 12/1 12/01/22 Sabre to replace Flagstar Bancorp in the S&P 600 at open on 12/1 01/11/23 PPL expects to generate 6% to 8% earnings and dividend growth through 2026 01/11/23 PPL expects to increase dividend 7% to 24c 01/05/23 PPL Corp. names Francis Sullivan as new COO 10/24/22 PPL Corp. and Elia Group to develop offshore wind capacity in New England 01/11/23 Veradigm announces new $250M share repurchase program 01/03/23 Allscripts changes corporate name to Veradigm 09/28/22 Allscripts reaffirms 2022 cash flow outlook of $110M-$120M 07/19/22 Pulse8 gets NCQA Measure Certification for HEDIS MY2022 for Qualit8 01/06/23 Southwest reports preliminary Q4 capacity down 6% vs. 4Q19 11/29/22 Livent and NTU Singapore announce research collaboration 11/25/22 Livent falls -10.6% 11/25/22 Livent falls -6.0% 09/12/22 Livent falls -6.6% 01/03/23 CarMax CEO buys $501K in common stock 12/22/22 CarMax falls -10.9% 12/22/22 CarMax CFO says lowering headcount through attrition 12/22/22 CarMax CEO expects average selling prices to 'continue to fall' 01/11/23 JinkoSolar rises 9.0% 01/11/23 JinkoSolar rises 5.3% 01/06/23 JinkoSolar rises 14.8% 01/06/23 JinkoSolar rises 7.0% 12/15/22 JetBlue launches partnership with NBCUniversal's Peacock streaming service $259.96 / -11.33 (-4.18%)
10/25/22 Intuitive Surgical reports $1B accelerated share repurchase agreement 10/19/22 Intuitive Surgical receives Royal College of Surgeons of England accreditation 10/18/22 Intuitive Surgical raises FY22 procedure growth view to 17%-18% from 14%-16.5% 10/18/22 Intuitive Surgical jumps 8% to $209.85 after Q3 results beat estimates 01/09/23 Illumina, Nashville Biosciences announce sequencing agreement with Amgen 12/05/22 European Commission says Illumina has to unwind Grail acquisition 11/02/22 Twist Bioscience and Illumina team on robust exome panel for research 10/18/22 Illumina enters partnership with GenoScreen in effort to end tuberculosis 01/10/23 Halozyme falls 7% to $52.00 after below-consensus FY23 guidance 01/10/23 Halozyme announces anticipated key events in 2023 09/21/22 Argenx submits SC efgartigimod BLA to FDA 08/02/22 Halozyme announces Roche IMscin001 study met its co-primary endpoints 01/10/23 Conn's extending gains afterhours on WSJ report of acquisition interest, up 13% 10/18/22 B. Riley Financial purchases second portfolio from Franchise Group subsidiary 01/09/23 Ginkgo Bioworks, Prokarium announce RNA collaboration 01/06/23 Ginkgo Bioworks expands R&D facilities 01/05/23 Cathie Wood's ARK Investment bought 1.16M shares of Ginkgo Bioworks today 01/05/23 Ginkgo Bioworks, Esperovax announce partnership to develop circular RNAs 01/05/23 Delta, T-Mobile to partner on free in-flight Wi-Fi for SkyMiles members 01/11/23 Salesforce Security CTO says leaving to join Evolution Equity Partners 01/04/23 Salesforce up 4% to $139.85 after announcing restructuring 01/04/23 Salesforce announces restructuring, 10% workforce reduction 12/08/22 Salesforce CEO: Planning for CRM to be second largest software company 01/10/23 Conn's trading resumes 01/10/23 Conn's trading halted, volatility trading pause 12/19/22 MasterBrand to replace Conn's in S&P 600 at open on 12/19 01/10/23 Cathie Wood's ARK Investment bought 33.8K shares of Coinbase today 01/10/23 Coinbase to cut workforce by about 950 employees in further restructuring 01/05/23 Cathie Wood's ARK Investment bought 172K shares of Coinbase today 01/04/23 Coinbase, NYDFS reach agreement to resolve compliance investigation 01/11/23 Air Lease announces Q4 activity update 01/10/23 ViaSat receives certificate in China to install connectivity in Boeing aircrafts 01/10/23 Boeing reports 774 commercial orders in 2022 01/10/23 Boeing announces total Q4 deliveries 152 aircraft 12/13/22 Axonics announces Health Canada approval of R20 neurostimulator 10/31/22 Axonics falls 7% to $67.90 after Q3 results and guidance 09/08/22 Axonics' sacral neuromodulation system implanted in first patient in Canada 08/17/22 Axonics expands sacral neuromodulation intellectual property portfolio 01/10/23 Alaska Air plans to hire more than 3,500 workers this year 12/19/22 Mesa Air to expand relationship with United, winds down contract with American 12/20/22 Deutsche Bank Spirit Airlines downgraded on regulatory process at Deutsche Bank 12/20/22 Deutsche Bank Spirit Airlines downgraded to Hold from Buy at Deutsche Bank 11/01/22 Citi Spirit Airlines price target raised to $23 from $22 at Citi 09/30/22 Citi Spirit Airlines reinstated with a Neutral at Citi (yesterday) 01/11/23 Jefferies Delta Air Lines price target raised to $45 from $40 at Jefferies 12/20/22 Deutsche Bank American Airlines price target lowered to $20 from $25 at Deutsche Bank 12/16/22 Goldman Sachs American Airlines resumed with a Neutral at Goldman Sachs 10/17/22 Citi American Airlines price target lowered to $15 from $16 at Citi 01/11/23 Morgan Stanley Wells exit from correspondent 'doesn't move EPS needle,' says Morgan Stanley 01/10/23 Odeon Capital Wells Fargo upgraded to Buy from Hold at Odeon Capital 01/06/23 Deutsche Bank Wells Fargo price target lowered to $50 from $60 at Deutsche Bank 01/03/23 Barclays Wells Fargo price target raised to $64 from $58 at Barclays 01/12/23 Barclays Alaska Air price target raised to $50 from $45 at Barclays 01/11/23 Barclays Alaska Air price target raised to $50 from $45 at Barclays 12/16/22 Goldman Sachs Alaska Air resumed with a Buy at Goldman Sachs 12/15/22 Cowen Copa Holdings upgraded to Outperform at Cowen amid airlines rating shake-up 01/12/23 Barclays Southwest price target lowered to $42 from $48 at Barclays 01/11/23 Susquehanna Susquehanna downgrades Southwest to Neutral on growing risks 01/11/23 Barclays Southwest price target lowered to $42 from $48 at Barclays 01/12/23 Barclays Delta Air Lines price target raised to $44 from $38 at Barclays 01/11/23 Barclays Delta Air Lines price target raised to $44 from $38 at Barclays 01/10/23 BofA Delta Air Lines price target raised to $43 from $40 at BofA 12/20/22 Deutsche Bank JetBlue price target lowered to $8.50 from $10 at Deutsche Bank 12/16/22 Goldman Sachs JetBlue resumed with a Not Rated at Goldman Sachs 12/15/22 Cowen JetBlue downgraded to Market Perform at Cowen amid airlines rating shake-up 01/12/23 Barclays United Airlines price target raised to $45 from $42 at Barclays 01/11/23 Barclays United Airlines price target raised to $45 from $42 at Barclays 12/16/22 Goldman Sachs United Airlines resumed with a Buy at Goldman Sachs 11/04/22 Barrington Franchise Group price target lowered to $35 from $40 at Barrington 08/05/22 B. Riley Franchise Group price target lowered to $49 from $63 at B. Riley 07/05/22 DA Davidson Franchise Group 'no worse off' than before without Kohl's, says DA Davidson 07/05/22 Baird Kohl's price target lowered to $42 from $53 at Baird 12/07/22 Stephens Conn's price target lowered to $9 from $13 at Stephens 04/11/22 Stephens Conn's assumed with an Equal Weight at Stephens 01/11/23 Goldman Sachs Goldman continues to prefer Tesla and GM among automakers 01/06/23 Piper Sandler Piper 'unsurprised' by Tesla decision to cut prices in China 01/06/23 BofA XPeng downgraded to Neutral at BofA after Tesla price cuts 01/06/23 GLJ Research Tesla price cuts in China 'much worse than you think,' says GLJ Research $259.96 / -11.33 (-4.18%)
01/11/23 Piper Sandler Intuitive Surgical procedure outlook set conservatively, says Piper Sandler 01/04/23 Barclays Intuitive Surgical price target raised to $298 from $235 at Barclays 01/03/23 BTIG Intuitive Surgical named Top Pick for first half of 2023 at BTIG 12/22/22 Argus Intuitive Surgical price target raised to $320 from $265 at Argus WBD Warner Bros. Discovery 01/11/23 Guggenheim Guggenheim upgrades Warner Bros. Discovery to Buy, sees 31% potential upside 01/11/23 Guggenheim Warner Bros. Discovery upgraded to Buy from Neutral at Guggenheim 01/10/23 BofA Warner Bros. Discovery added to 'US 1 List' at BofA 01/04/23 Macquarie Warner Bros. Discovery price target lowered to $16 from $18 at Macquarie 01/11/23 Bernstein Salesforce downgraded to Underperform from Market Perform at Bernstein 01/09/23 Piper Sandler Salesforce price target lowered to $171 from $175 at Piper Sandler 01/05/23 Loop Capital Salesforce price target lowered to $140 from $150 at Loop Capital 01/05/23 Cowen Salesforce price target lowered to $175 from $195 at Cowen 01/12/23 Barclays Coinbase price target raised to $45 from $37 at Barclays 01/11/23 DA Davidson Coinbase price target lowered to $55 from $70 at DA Davidson 01/11/23 Mizuho Coinbase workforce cut does not fix number one problem, says Mizuho 01/11/23 BofA Coinbase downgraded to Underperform at BofA on below-Street 2023 view 01/11/23 JPMorgan CarMax downgraded to Underweight from Neutral at JPMorgan 01/05/23 Argus CarMax downgraded to Hold from Buy at Argus 12/28/22 Morgan Stanley CarMax price target lowered to $75 from $90 at Morgan Stanley 12/28/22 Wedbush Wedbush reiterates Underperform on Carvana on weakening results, liquidity 01/11/23 Roth MKM JinkoSolar upgraded to Buy from Neutral at Roth Capital 12/02/22 RBC Capital RBC Capital 'not surprised' by Commerce Department's finding on solar companies 12/01/22 Roth MKM U.S. to announce 'affirmative' finding in solar trade case, says Roth Capital 11/10/22 Morgan Stanley New California 'NEM 3.0' proposal 'screens positive,' says Morgan Stanley 01/10/23 Citi Citi says WWE sale possible, ups price target to $110 01/06/23 Loop Capital WWE price target raised to $105 from $90 at Loop Capital 01/06/23 MKM Partners MKM Partners sees WWE as 'very attractive asset' if it goes for sale 11/29/22 Morgan Stanley WWE price target raised to $80 from $75 at Morgan Stanley 01/10/23 Morgan Stanley Stem upgraded to Overweight from Equal Weight at Morgan Stanley 01/08/23 UBS Stem price target lowered to $18 from $19 at UBS 10/25/22 UBS Stem initiated with a Buy at UBS on leading position in commercial storage 10/25/22 UBS Stem initiated with a Buy at UBS 01/12/23 Credit Suisse Credit Suisse upgrades Boeing to Neutral, raises price target to $200 01/12/23 Credit Suisse Boeing upgraded to Neutral from Underperform at Credit Suisse 01/11/23 Wells Fargo Boeing price target raised to $240 from $218 at Wells Fargo 01/11/23 Wells Fargo Boeing, Equinix added to Signature Picks at Wells Fargo 01/12/23 Mizuho PPL Corp. price target raised to $32 from $30 at Mizuho 12/15/22 Morgan Stanley PPL Corp. upgraded to Overweight from Equal Weight at Morgan Stanley 10/24/22 Guggenheim PPL Corp. price target lowered to $27 from $33 at Guggenheim 10/06/22 Seaport Global PPL Corp. upgraded to Buy from Neutral at Seaport Global 01/10/23 BofA Illumina price target lowered to $210 from $220 at BofA 01/10/23 Cowen Illumina price target lowered to $296 from $350 at Cowen 01/10/23 Citi Illumina guided 2023 significantly below expectations, says Citi 01/05/23 Scotiabank Illumina initiated with Sector Perform on Grail uncertainty Scotiabank 01/11/23 BofA shakes up ratings to get 'more offensive' in U.S. Chemicals 01/11/23 BofA Livent upgraded to Buy from Underperform at BofA 01/10/23 Deutsche Bank Livent price target lowered to $22 from $30 at Deutsche Bank 01/04/23 Vertical Research Livent upgraded to Buy from Hold at Vertical Research 11/28/22 Berenberg Berenberg starts 'well-positioned' disruptor Ginkgo Bioworks with a Buy 11/28/22 Berenberg Ginkgo Bioworks initiated with a Buy at Berenberg 10/04/22 Morgan Stanley Ginkgo Bioworks initiated with an Equal Weight at Morgan Stanley 08/16/22 BTIG Ginkgo Bioworks price target raised to $6 from $5 at BTIG 01/11/23 BofA Sabre downgraded to Underperform from Buy at BofA 10/17/22 Mizuho Sabre price target lowered to $6 from $7 at Mizuho 09/28/22 Redburn Sabre initiated with a Buy at Redburn 09/08/22 Mizuho Sabre price target lowered to $7 from $8 at Mizuho 12/21/22 Morgan Stanley Halozyme assumed with an Overweight at Morgan Stanley 12/08/22 Benchmark Halozyme price target raised to $68 from $55 at Benchmark 11/28/22 Wells Fargo Halozyme initiated with an Overweight at Wells Fargo 09/09/22 Morgan Stanley Halozyme initiated with an Overweight at Morgan Stanley 11/29/22 RBC Capital GDS Holdings price target lowered to $15 from $22 at RBC Capital 11/23/22 Truist GDS Holdings price target lowered to $50 from $75 at Truist 11/23/22 HSBC GDS Holdings price target lowered to $36 from $39 at HSBC 08/26/22 RBC Capital GDS Holdings downgraded to Sector Perform from Outperform at RBC Capital 01/12/23 BofA Ubisoft guidance cut not a negative read to Take-Two, EA, says BofA 01/12/23 Societe Generale Ubisoft downgraded to Sell from Hold at Societe Generale 01/12/23 JPMorgan Ubisoft downgraded to Neutral from Overweight at JPMorgan 01/11/23 Morgan Stanley Ubisoft price target lowered to EUR 33 from EUR 52 at Morgan Stanley 12/07/22 Argus Allscripts upgraded to Buy at Argus on expanding margins, attractive valuation 12/07/22 Argus Allscripts upgraded to Buy from Hold at Argus 11/08/22 Goldman Sachs Allscripts upgraded to Buy from Neutral at Goldman Sachs 11/04/22 Piper Sandler Allscripts assumed with an Overweight at Piper Sandler 01/05/23 UBS UBS cuts Victoria's Secret to Sell, sees earnings outlook deteriorate in 2023 01/05/23 UBS Victoria's Secret downgraded to Sell from Neutral at UBS 12/27/22 UBS UBS 'not bullish' on Victoria's Secret turnaround potential 12/02/22 Cowen Victoria's Secret price target raised to $45 from $35 at Cowen 11/01/22 Truist Axonics price target raised to $90 from $80 at Truist 11/01/22 Wells Fargo Axonics price target raised to $90 from $83 at Wells Fargo 10/21/22 RBC Capital Axonics initiated with an Outperform at RBC Capital 10/17/22 Truist Axonics price target lowered to $80 from $85 at Truist 12/13/22 Piper Sandler Piper 'cautious' on Tandem Diabetes acquisition but stays Overweight 12/12/22 Citi Tandem Diabetes price target raised to $55 from $50 at Citi 11/15/22 Wells Fargo Wells Fargo upgrades Tandem Diabetes to Equal Weight with $43 price target 11/15/22 Wells Fargo Tandem Diabetes upgraded to Equal Weight from Underweight at Wells Fargo 11/02/22 WWE reports Q3 EPS 49c, consensus 50c 08/16/22 WWE reports Q2 adjusted EPS 59c vs. 34c last year 07/25/22 WWE reports preliminary Q2 revenue $328M, consensus $311.84M 10/14/22 Wells Fargo reports Q3 EPS 85c, consensus $1.09 10/13/22 Notable companies reporting before tomorrow's open 07/15/22 Wells Fargo reports Q2 EPS 74c, consensus 86c WBD Warner Bros. Discovery 11/03/22 Warner Bros. Discovery reports Q3 EPS (95c), consensus (21c) 11/03/22 Warner Bros. Discovery reports Q3 revenue $9.82B, consensus $10.36B 11/03/22 Notable companies reporting after market close 08/04/22 Warner Bros. Discovery cuts FY22 adjusted EBITDA view to $9.0B-$9.5B 01/11/23 Victoria's Secret narrows Q4 EPS view to $2.05-$2.25 from $2.00-$2.45 11/30/22 Victoria's Secret sees FY22 EPS $4.50-$4.95, consensus $4.73 11/30/22 Victoria's Secret sees Q4 EPS $2.00-$2.45, consensus $2.32 11/30/22 Victoria's Secret reports Q3 EPS 29c, consensus 23c 01/11/23 Ubisoft cuts Q3 net bookings view to EUR725M from EUR830M 01/11/23 Ubisoft cuts FY23 operating income view to (EUR500M) from EUR400M 07/21/22 Ubisoft sees Q2 net bookings EUR 270M, confirms 2022 income target 07/21/22 Ubisoft reports Q1 sales EUR 318.2M, down 9.8% vs. last year 10/18/22 United Airlines sees Q4 adjusted EPS $2.00-$2.25, consensus 98c 10/18/22 United Airlines reports Q3 adjusted EPS $2.81, consensus $2.27 10/18/22 Notable companies reporting after market close 07/20/22 United Airlines reports Q2 EPS $1.43, consensus $1.94 10/19/22 Tesla reports Q3 EPS $1.05, consensus 99c 10/19/22 Notable companies reporting after market close 07/20/22 Tesla reports Q2 EPS $2.27, consensus $1.85 07/20/22 Notable companies reporting after market close 01/10/23 Tandem Diabetes sees FY22 revenue at 'approximately' $805M, consensus $802.5M 01/10/23 Tandem Diabetes reports preliminary Q4 revenue at $224M, consensus $221.6M 11/02/22 Tandem Diabetes cuts FY22 revenue view to $800M-$805M, consensus $836.4M 11/02/22 Tandem Diabetes reports Q3 EPS (76c), consensus (5c) 11/03/22 Stem reports Q3 EPS (22c), consensus (17c) 08/04/22 Stem backs FY22 revenue view of $350M-$425M, consensus $391.1M 08/04/22 Stem reports Q2 EPS (21c), consensus (18c) 10/26/22 Spirit Airlines reports Q3 adjusted EPS 3c, consensus (10c) 10/26/22 Notable companies reporting after market close 08/09/22 Spirit Airlines reports Q2 EPS (48c) vs. (34c) last year 11/02/22 Sabre sees FY22 adjusted EBITDA ~$90M 11/02/22 Sabre sees Q4 adjusted EBITDA ~$30M 11/02/22 Sabre reports Q3 adjusted EPS (25c), consensus (25c) 08/02/22 Sabre now sees FY22 revenue $2.3B-$2.6B at 50% bookings recovery 01/11/23 PPL sees FY23 EPS $1.50-$1.65, consensus $1.59 11/04/22 PPL narrows FY22 EPS view to $1.35-$1.45 from $1.30-$1.45 11/04/22 PPL reports Q3 adjusted EPS 41c, consensus 42c 08/03/22 PPL Corp. backs 2022 ongoing EPS view $1.30-$1.45, consensus $1.42 01/11/23 Veradigm sees FY23 EPS 90c-$1.00, consensus 95c 11/03/22 Allscripts backs FY22 Veradigm revenue growth view 6%-7% 11/03/22 Allscripts reports Q3 adjusted EPS 23c, consensus 19c 08/04/22 Allscripts backs FY22 Veradigm revenue growth view 6%-7% 10/27/22 Southwest sees FY22 ASMs down 4.5% 10/27/22 Southwest sees Q4 revenue up 13%-17%, consensus $6.23B 10/27/22 Southwest reports Q3 adjusted EPS 50c, consensus 42c 10/26/22 Notable companies reporting before tomorrow's open 11/01/22 Livent narrows FY22 revenue view to $815M-$845M from $800M-$860M 11/01/22 Livent reports Q3 EPS 41c, consensus 40c 08/02/22 Livent raises FY22 revenue to $800M-$860M from $755M-$835M 08/02/22 Livent reports Q2 GAAP EPS 31c, consensus 29c 12/22/22 CarMax reports Q3 EPS 24c, consensus 70c 12/21/22 Notable companies reporting before tomorrow's open 09/29/22 CarMax reports Q2 EPS 79c, consensus $1.39 10/28/22 JinkoSolar reports Q3 EPS 90c, consensus 71c 08/26/22 JinkoSolar reports Q2 EPS ($1.88), consensus 38c 10/25/22 JetBlue reports Q3 adjusted EPS 21c, consensus 24c 10/24/22 Notable companies reporting before tomorrow's open 09/16/22 JetBlue raises Q3 RASM growth view to 22%-24% year over three $259.96 / -11.33 (-4.18%)
01/11/23 Intuitive Surgical sees Q4 revenue $1.66B, consensus $1.68B 10/18/22 Intuitive Surgical reports Q3 EPS $1.19, consensus $1.12 07/21/22 Intuitive Surgical reports Q2 EPS $1.14, consensus $1.19 11/03/22 Illumina sees FY22 adjusted EPS $2.35-$2.50, consensus $2.78 11/03/22 Illumina reports Q3 adjusted EPS 34c, consensus 30c 10/03/22 Illumina sees giving detailed FY23 guidance in February 01/10/23 Halozyme sees FY23 adjusted EPS $2.50-$2.65, consensus $2.90 11/08/22 Halozyme reaffirms FY22 non-GAAP EPS view $2.10-$2.25, consensus $2.04 11/08/22 Halozyme reports Q3 non-GAAP EPS 74c, consensus 51c 08/09/22 Halozyme raises FY22 non-GAAP EPS view to $2.10-$2.25 from $2.05-$2.20 11/21/22 GDS Holdings reports Q3 EPS (3c), consensus (30c) 08/23/22 GDS Holdings sees 2022 revenue RMB 9.25B - RMB 9.4B 08/23/22 GDS Holdings reports Q2 EPS (32c), consensus (30c) 11/03/22 Franchise Group now sees FY22 EPS $3.25-$4.00, consensus $4.01 11/03/22 Franchise Group reports Q3 EPS 59c, consensus 71c 01/11/23 Ginkgo Bioworks backs FY22 revenue view $460M-$480M, consensus $470.79M 11/14/22 Ginkgo Bioworks sees FY22 revenue $425M-$440M, consensus $435.34M 11/14/22 Ginkgo Bioworks reports Q3 EPS (41c), consensus (30c) 08/15/22 Ginkgo Bioworks raises FY22 revenue view to $425M-$440M from $375M-$390M 12/14/22 Delta Air Lines raises Q4 adjusted EPS view to $1.35-$1.40 from $1.00-$1.25 12/14/22 Delta Air Lines sees FY23 adjusted EPS $5.00-$6.00, consensus $4.80 12/14/22 Delta Air Lines sees FY22 revenue view $45.5B-$45.6B, consensus $45.54B 12/14/22 Delta Air Lines sees FY22 adjusted EPS $3.07-$3.12, consensus $2.89 11/30/22 Salesforce raises FY23 EPS view to $4.92-$4.94, consensus $4.73 11/30/22 Salesforce sees Q4 EPS $1.35-$1.37, consensus $1.34 11/30/22 Salesforce reports Q3 EPS $1.40, consensus $1.21 11/30/22 Notable companies reporting after market close 12/06/22 Conn's reports Q3 non-GAAP EPS (78c), consensus (83c) 10/18/22 Conn's withdraws FY23 financial guidance 10/18/22 Conn's sees Q3 revenue down 21%-23%, consensus $326.11M 08/30/22 Conn's reports Q2 adjusted EPS 4c, consensus 9c 01/10/23 Coinbase sees FY22 adjusted EBITDA within negative $500M loss 'guardrail' 12/07/22 Coinbase CEO tells Bloomberg 2022 revenue seen down 50% or more 11/03/22 Coinbase reports Q3 EPS ($2.43), consensus ($2.40) 10/26/22 Boeing reports Q3 core EPS ($6.18), consensus 2c 10/25/22 Notable companies reporting before tomorrow's open 07/27/22 Boeing reports Q2 core EPS (37c), consensus (16c) 01/11/23 Axonics sees FY23 revenue $342M, consensus $327.2M 01/11/23 Axonics sees Q4 revenue $85.6M-$86.0M, consensus $74.3M 10/31/22 Axonics raises FY22 revenue view to $262M from $253M, consensus $254.0M 10/31/22 Axonics reports Q3 EPS (34c), consensus (48c) 10/20/22 Alaska Air sees FY22 capacity down 8%-9% vs. 2019 10/20/22 Alaska Air reports Q3 adjusted EPS $2.53, consensus $2.39 10/20/22 American Airlines sees Q4 EPS ex-items 50c-70c, consensus 22c 10/20/22 American Airlines reports Q3 EPS 69c, consensus 56c 10/19/22 Notable companies reporting before tomorrow's open
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
01/10/23 WWE board elects Vince McMahon Executive Chairman of the Board 01/10/23 WWE co-CEO Stephanie McMahon announces resignation 01/09/23 WWE announces WrestleMania in Los Angeles breaks all-time gate record 01/06/23 WWE rises 22.2% 01/10/23 Wells Fargo exits Correspondent business, to reduce size of Servicing portfolio 01/03/23 Federal regulators issue joint statement on crypto-asset risks to banks 12/20/22 Wells Fargo to pay $1.7B in CFPB settlement, expects $3.5B in operating losses 12/20/22 Wells Fargo ordered to pay $3.7B by CFPB for mismanagement of auto loans WBD Warner Bros. Discovery 01/03/23 Warner Bros. Discovery enters audience measurement agreement with VideoAmp 01/02/23 Fly Intel: Top five weekend stock stories 12/14/22 Warner Bros.' game 'Hogwarts Legacy' to launch on Switch July 25, 2023 12/06/22 Warner Bros. Discovery, Amazon.com: HBO Max available on Prime Video in U.S. 01/11/23 Victoria's Secret approves $250M new share repurchase program 01/05/23 Victoria's Secret falls -9.1% 01/03/23 Victoria's Secret says Hauk resigns as Brand CEO 11/14/22 Greenlight takes new stake in Intel, exits position in Atlas Air 12/29/22 Mesa Air finalizes capacity agreement with United Airlines 01/10/23 Cathie Wood's ARK Investment bought 101K shares of Tesla today 01/09/23 Cathie Wood's ARK Investment bought 27.8K shares of Tesla today 01/08/23 Fly Intel: Top five weekend stock stories 01/04/23 Cathie Wood's ARK Investment bought 21K shares of Tesla today 12/13/22 Tandem Diabetes to acquire AMF Medical 11/10/22 Tandem Diabetes t:slim X2 care study demonstrates improvement in all endpoints 09/08/22 Tandem Diabetes CFO says 'goal is always to beat' guidance 09/08/22 Tandem Diabetes CEO saw 'positive shift,' start of 'momentum build' in August 01/11/23 Stem falls -6.0% 01/11/23 Blue Orca short Stem, says 'has all landmarks of failed SPAC' 01/11/23 Stem down 7% after Blue Orca makes accusations in short report 01/10/23 Stem rises 9.1% 11/20/22 Fly Intel: Top five weekend stock stories 12/01/22 Nexstar to replace Sabre in the S&P 400 at open on 12/1 12/01/22 Sabre to replace Flagstar Bancorp in the S&P 600 at open on 12/1 01/11/23 Veradigm announces new $250M share repurchase program 01/03/23 Allscripts changes corporate name to Veradigm 09/28/22 Allscripts reaffirms 2022 cash flow outlook of $110M-$120M 07/19/22 Pulse8 gets NCQA Measure Certification for HEDIS MY2022 for Qualit8 01/06/23 Southwest reports preliminary Q4 capacity down 6% vs. 4Q19 $22.92 / +2.145 (+10.32%)
11/29/22 Livent and NTU Singapore announce research collaboration 11/25/22 Livent falls -10.6% 11/25/22 Livent falls -6.0% 09/12/22 Livent falls -6.6% 01/03/23 CarMax CEO buys $501K in common stock 12/22/22 CarMax falls -10.9% 12/22/22 CarMax CFO says lowering headcount through attrition 12/22/22 CarMax CEO expects average selling prices to 'continue to fall' 01/11/23 JinkoSolar rises 9.0% 01/11/23 JinkoSolar rises 5.3% 01/06/23 JinkoSolar rises 14.8% 01/06/23 JinkoSolar rises 7.0% 12/15/22 JetBlue launches partnership with NBCUniversal's Peacock streaming service $256.98 / -14.31 (-5.27%)
10/25/22 Intuitive Surgical reports $1B accelerated share repurchase agreement 10/19/22 Intuitive Surgical receives Royal College of Surgeons of England accreditation 10/18/22 Intuitive Surgical raises FY22 procedure growth view to 17%-18% from 14%-16.5% 10/18/22 Intuitive Surgical jumps 8% to $209.85 after Q3 results beat estimates 01/10/23 Halozyme falls 7% to $52.00 after below-consensus FY23 guidance 01/10/23 Halozyme announces anticipated key events in 2023 09/21/22 Argenx submits SC efgartigimod BLA to FDA 08/02/22 Halozyme announces Roche IMscin001 study met its co-primary endpoints 01/10/23 Conn's extending gains afterhours on WSJ report of acquisition interest, up 13% 10/18/22 B. Riley Financial purchases second portfolio from Franchise Group subsidiary 01/09/23 Ginkgo Bioworks, Prokarium announce RNA collaboration 01/06/23 Ginkgo Bioworks expands R&D facilities 01/05/23 Cathie Wood's ARK Investment bought 1.16M shares of Ginkgo Bioworks today 01/05/23 Ginkgo Bioworks, Esperovax announce partnership to develop circular RNAs 01/11/23 Disneyland Resort announces new update, offer guests more value 01/03/23 Imax: 'Avatar: The Way of Water' ends 2022 as highest grossing release of year 01/05/23 Delta, T-Mobile to partner on free in-flight Wi-Fi for SkyMiles members 01/04/23 Salesforce up 4% to $139.85 after announcing restructuring 01/04/23 Salesforce announces restructuring, 10% workforce reduction 12/08/22 Salesforce CEO: Planning for CRM to be second largest software company 12/06/22 Sprout, Salesforce deepen partnership with addition of Tableau 01/10/23 Conn's trading resumes 01/10/23 Conn's trading halted, volatility trading pause 12/19/22 MasterBrand to replace Conn's in S&P 600 at open on 12/19 01/10/23 Cathie Wood's ARK Investment bought 33.8K shares of Coinbase today 01/10/23 Coinbase to cut workforce by about 950 employees in further restructuring 01/05/23 Cathie Wood's ARK Investment bought 172K shares of Coinbase today 01/04/23 Coinbase, NYDFS reach agreement to resolve compliance investigation 01/10/23 Eisai submits MAA for lecanemab to EMA 01/09/23 Ionis Pharmaceuticals, Royalty Pharma enter $1.1B royalty agreement 01/08/23 Eisai submits sBLA to FDA for traditional approval of LEQEMBI in Alzheimer's 01/06/23 CMS says Biogen approval falls under existing national coverage determination 01/11/23 Air Lease announces Q4 activity update 01/10/23 ViaSat receives certificate in China to install connectivity in Boeing aircrafts 01/10/23 Boeing reports 774 commercial orders in 2022 01/10/23 Boeing announces total Q4 deliveries 152 aircraft 12/13/22 Axonics announces Health Canada approval of R20 neurostimulator 10/31/22 Axonics falls 7% to $67.90 after Q3 results and guidance 09/08/22 Axonics' sacral neuromodulation system implanted in first patient in Canada 08/17/22 Axonics expands sacral neuromodulation intellectual property portfolio 01/11/23 FAA says 'ground stop has been lifted' 01/11/23 FAA 'making progress' in restoring NOAM system following outage 01/11/23 U.S. flights disrupted amid outage of FAA pilot advisory system 01/10/23 Alaska Air plans to hire more than 3,500 workers this year 12/19/22 Mesa Air to expand relationship with United, winds down contract with American 01/11/23 Morgan Stanley Wells exit from correspondent 'doesn't move EPS needle,' says Morgan Stanley 01/10/23 Odeon Capital Wells Fargo upgraded to Buy from Hold at Odeon Capital 01/06/23 Deutsche Bank Wells Fargo price target lowered to $50 from $60 at Deutsche Bank 01/03/23 Barclays Wells Fargo price target raised to $64 from $58 at Barclays 01/11/23 Barclays Alaska Air price target raised to $50 from $45 at Barclays 12/16/22 Goldman Sachs Alaska Air resumed with a Buy at Goldman Sachs 12/15/22 Cowen Copa Holdings upgraded to Outperform at Cowen amid airlines rating shake-up 12/05/22 Citi Alaska Air initiated with a Buy at Citi 01/11/23 Jefferies Delta Air Lines price target raised to $45 from $40 at Jefferies 01/11/23 Susquehanna Susquehanna downgrades Southwest to Neutral on growing risks 01/11/23 Barclays Southwest price target lowered to $42 from $48 at Barclays 01/11/23 Susquehanna Southwest downgraded to Neutral from Positive at Susquehanna 01/11/23 Barclays Delta Air Lines price target raised to $44 from $38 at Barclays 01/10/23 BofA Delta Air Lines price target raised to $43 from $40 at BofA 01/05/23 Argus Delta upgraded to Buy at Argus on strong leisure and recovery in business travel 12/20/22 Deutsche Bank JetBlue price target lowered to $8.50 from $10 at Deutsche Bank 12/20/22 Deutsche Bank Spirit Airlines downgraded on regulatory process at Deutsche Bank 12/16/22 Goldman Sachs JetBlue resumed with a Not Rated at Goldman Sachs 12/15/22 Cowen JetBlue downgraded to Market Perform at Cowen amid airlines rating shake-up 01/11/23 Barclays United Airlines price target raised to $45 from $42 at Barclays 12/16/22 Goldman Sachs United Airlines resumed with a Buy at Goldman Sachs 12/20/22 Deutsche Bank Spirit Airlines downgraded to Hold from Buy at Deutsche Bank 11/01/22 Citi Spirit Airlines price target raised to $23 from $22 at Citi 09/30/22 Citi Spirit Airlines reinstated with a Neutral at Citi (yesterday) 12/20/22 Deutsche Bank American Airlines price target lowered to $20 from $25 at Deutsche Bank 12/16/22 Goldman Sachs American Airlines resumed with a Neutral at Goldman Sachs 10/17/22 Citi American Airlines price target lowered to $15 from $16 at Citi 11/04/22 Barrington Franchise Group price target lowered to $35 from $40 at Barrington 08/05/22 B. Riley Franchise Group price target lowered to $49 from $63 at B. Riley 07/05/22 DA Davidson Franchise Group 'no worse off' than before without Kohl's, says DA Davidson 07/05/22 Baird Kohl's price target lowered to $42 from $53 at Baird 12/07/22 Stephens Conn's price target lowered to $9 from $13 at Stephens 04/11/22 Stephens Conn's assumed with an Equal Weight at Stephens 01/11/23 Goldman Sachs Goldman continues to prefer Tesla and GM among automakers 01/06/23 Piper Sandler Piper 'unsurprised' by Tesla decision to cut prices in China 01/06/23 BofA XPeng downgraded to Neutral at BofA after Tesla price cuts 01/06/23 GLJ Research Tesla price cuts in China 'much worse than you think,' says GLJ Research $256.98 / -14.31 (-5.27%)
01/04/23 Barclays Intuitive Surgical price target raised to $298 from $235 at Barclays 01/03/23 BTIG Intuitive Surgical named Top Pick for first half of 2023 at BTIG 12/22/22 Argus Intuitive Surgical price target raised to $320 from $265 at Argus 12/12/22 Citi Intuitive Surgical price target raised to $318 from $245 at Citi WBD Warner Bros. Discovery 01/11/23 Guggenheim Guggenheim upgrades Warner Bros. Discovery to Buy, sees 31% potential upside 01/11/23 Guggenheim Warner Bros. Discovery upgraded to Buy from Neutral at Guggenheim 01/10/23 BofA Warner Bros. Discovery added to 'US 1 List' at BofA 01/04/23 Macquarie Warner Bros. Discovery price target lowered to $16 from $18 at Macquarie 01/11/23 Bernstein Salesforce downgraded to Underperform from Market Perform at Bernstein 01/09/23 Piper Sandler Salesforce price target lowered to $171 from $175 at Piper Sandler 01/05/23 Loop Capital Salesforce price target lowered to $140 from $150 at Loop Capital 01/05/23 Cowen Salesforce price target lowered to $175 from $195 at Cowen 01/11/23 DA Davidson Coinbase price target lowered to $55 from $70 at DA Davidson 01/11/23 Mizuho Coinbase workforce cut does not fix number one problem, says Mizuho 01/11/23 BofA Coinbase downgraded to Underperform at BofA on below-Street 2023 view 01/11/23 BofA Coinbase downgraded to Underperform from Neutral at BofA 01/11/23 JPMorgan CarMax downgraded to Underweight from Neutral at JPMorgan 01/05/23 Argus CarMax downgraded to Hold from Buy at Argus 12/28/22 Morgan Stanley CarMax price target lowered to $75 from $90 at Morgan Stanley 12/28/22 Wedbush Wedbush reiterates Underperform on Carvana on weakening results, liquidity 01/11/23 Roth MKM JinkoSolar upgraded to Buy from Neutral at Roth Capital 12/02/22 RBC Capital RBC Capital 'not surprised' by Commerce Department's finding on solar companies 12/01/22 Roth MKM U.S. to announce 'affirmative' finding in solar trade case, says Roth Capital 11/10/22 Morgan Stanley New California 'NEM 3.0' proposal 'screens positive,' says Morgan Stanley 01/10/23 Citi Citi says WWE sale possible, ups price target to $110 01/06/23 Loop Capital WWE price target raised to $105 from $90 at Loop Capital 01/06/23 MKM Partners MKM Partners sees WWE as 'very attractive asset' if it goes for sale 11/29/22 Morgan Stanley WWE price target raised to $80 from $75 at Morgan Stanley 01/10/23 Morgan Stanley Stem upgraded to Overweight from Equal Weight at Morgan Stanley 01/08/23 UBS Stem price target lowered to $18 from $19 at UBS 10/25/22 UBS Stem initiated with a Buy at UBS on leading position in commercial storage 10/25/22 UBS Stem initiated with a Buy at UBS 01/11/23 Wells Fargo Boeing price target raised to $240 from $218 at Wells Fargo 01/11/23 Wells Fargo Boeing, Equinix added to Signature Picks at Wells Fargo 01/11/23 JPMorgan Boeing price target raised to $207 from $200 at JPMorgan 01/10/23 Morgan Stanley Boeing downgraded to Equal Weight from Overweight at Morgan Stanley 01/10/23 RBC Capital FDA review suggests high amenability for a full leca approval, says RBC Capital 01/08/23 BofA Biogen receives 'fairly benign' label for Alzheimer's drug, says BofA 01/08/23 UBS Biogen Alzheimer's drug label 'essentially best case,' says UBS 01/06/23 Piper Sandler Piper stays on sidelines as commercial success of Biogen's Leqembi unsure 01/04/23 Macquarie Disney price target lowered to $110 from $120 at Macquarie 12/20/22 Wells Fargo Wells says Disney spinning ESPN/ABC 'a reasonably probable event' for late 2023 12/12/22 Morgan Stanley Disney price target lowered to $115 from $125 at Morgan Stanley 12/07/22 Argus Allscripts upgraded to Buy at Argus on expanding margins, attractive valuation 12/07/22 Argus Allscripts upgraded to Buy from Hold at Argus 11/08/22 Goldman Sachs Allscripts upgraded to Buy from Neutral at Goldman Sachs 11/04/22 Piper Sandler Allscripts assumed with an Overweight at Piper Sandler 01/05/23 UBS UBS cuts Victoria's Secret to Sell, sees earnings outlook deteriorate in 2023 01/05/23 UBS Victoria's Secret downgraded to Sell from Neutral at UBS 12/27/22 UBS UBS 'not bullish' on Victoria's Secret turnaround potential 12/02/22 Cowen Victoria's Secret price target raised to $45 from $35 at Cowen 11/01/22 Truist Axonics price target raised to $90 from $80 at Truist 11/01/22 Wells Fargo Axonics price target raised to $90 from $83 at Wells Fargo 10/21/22 RBC Capital Axonics initiated with an Outperform at RBC Capital 10/17/22 Truist Axonics price target lowered to $80 from $85 at Truist 12/13/22 Piper Sandler Piper 'cautious' on Tandem Diabetes acquisition but stays Overweight 12/12/22 Citi Tandem Diabetes price target raised to $55 from $50 at Citi 11/15/22 Wells Fargo Wells Fargo upgrades Tandem Diabetes to Equal Weight with $43 price target 11/15/22 Wells Fargo Tandem Diabetes upgraded to Equal Weight from Underweight at Wells Fargo 12/21/22 Barclays InMode initiated with an Overweight at Barclays 10/12/22 Jefferies InMode initiated with a Buy at Jefferies 07/29/22 Baird InMode price target raised to $53 from $44 at Baird 07/13/22 Baird InMode price target lowered to $44 from $57 at Baird $22.92 / +2.145 (+10.32%)
01/11/23 BofA shakes up ratings to get 'more offensive' in U.S. Chemicals 01/11/23 BofA Livent upgraded to Buy from Underperform at BofA 01/10/23 Deutsche Bank Livent price target lowered to $22 from $30 at Deutsche Bank 01/04/23 Vertical Research Livent upgraded to Buy from Hold at Vertical Research 11/28/22 Berenberg Berenberg starts 'well-positioned' disruptor Ginkgo Bioworks with a Buy 11/28/22 Berenberg Ginkgo Bioworks initiated with a Buy at Berenberg 10/04/22 Morgan Stanley Ginkgo Bioworks initiated with an Equal Weight at Morgan Stanley 08/16/22 BTIG Ginkgo Bioworks price target raised to $6 from $5 at BTIG 01/11/23 BofA Sabre downgraded to Underperform from Buy at BofA 10/17/22 Mizuho Sabre price target lowered to $6 from $7 at Mizuho 09/28/22 Redburn Sabre initiated with a Buy at Redburn 09/08/22 Mizuho Sabre price target lowered to $7 from $8 at Mizuho 12/21/22 Morgan Stanley Halozyme assumed with an Overweight at Morgan Stanley 12/08/22 Benchmark Halozyme price target raised to $68 from $55 at Benchmark 11/28/22 Wells Fargo Halozyme initiated with an Overweight at Wells Fargo 09/09/22 Morgan Stanley Halozyme initiated with an Overweight at Morgan Stanley 11/29/22 RBC Capital GDS Holdings price target lowered to $15 from $22 at RBC Capital 11/23/22 Truist GDS Holdings price target lowered to $50 from $75 at Truist 11/23/22 HSBC GDS Holdings price target lowered to $36 from $39 at HSBC 08/26/22 RBC Capital GDS Holdings downgraded to Sector Perform from Outperform at RBC Capital 11/02/22 WWE reports Q3 EPS 49c, consensus 50c 08/16/22 WWE reports Q2 adjusted EPS 59c vs. 34c last year 07/25/22 WWE reports preliminary Q2 revenue $328M, consensus $311.84M 10/14/22 Wells Fargo reports Q3 EPS 85c, consensus $1.09 10/13/22 Notable companies reporting before tomorrow's open 07/15/22 Wells Fargo reports Q2 EPS 74c, consensus 86c WBD Warner Bros. Discovery 11/03/22 Warner Bros. Discovery reports Q3 EPS (95c), consensus (21c) 11/03/22 Warner Bros. Discovery reports Q3 revenue $9.82B, consensus $10.36B 11/03/22 Notable companies reporting after market close 08/04/22 Warner Bros. Discovery cuts FY22 adjusted EBITDA view to $9.0B-$9.5B 01/11/23 Victoria's Secret narrows Q4 EPS view to $2.05-$2.25 from $2.00-$2.45 11/30/22 Victoria's Secret sees FY22 EPS $4.50-$4.95, consensus $4.73 11/30/22 Victoria's Secret sees Q4 EPS $2.00-$2.45, consensus $2.32 11/30/22 Victoria's Secret reports Q3 EPS 29c, consensus 23c 10/18/22 United Airlines sees Q4 adjusted EPS $2.00-$2.25, consensus 98c 10/18/22 United Airlines reports Q3 adjusted EPS $2.81, consensus $2.27 10/18/22 Notable companies reporting after market close 07/20/22 United Airlines reports Q2 EPS $1.43, consensus $1.94 10/19/22 Tesla reports Q3 EPS $1.05, consensus 99c 10/19/22 Notable companies reporting after market close 07/20/22 Tesla reports Q2 EPS $2.27, consensus $1.85 07/20/22 Notable companies reporting after market close 01/10/23 Tandem Diabetes sees FY22 revenue at 'approximately' $805M, consensus $802.5M 01/10/23 Tandem Diabetes reports preliminary Q4 revenue at $224M, consensus $221.6M 11/02/22 Tandem Diabetes cuts FY22 revenue view to $800M-$805M, consensus $836.4M 11/02/22 Tandem Diabetes reports Q3 EPS (76c), consensus (5c) 11/03/22 Stem reports Q3 EPS (22c), consensus (17c) 08/04/22 Stem backs FY22 revenue view of $350M-$425M, consensus $391.1M 08/04/22 Stem reports Q2 EPS (21c), consensus (18c) 10/26/22 Spirit Airlines reports Q3 adjusted EPS 3c, consensus (10c) 10/26/22 Notable companies reporting after market close 08/09/22 Spirit Airlines reports Q2 EPS (48c) vs. (34c) last year 11/02/22 Sabre sees FY22 adjusted EBITDA ~$90M 11/02/22 Sabre sees Q4 adjusted EBITDA ~$30M 11/02/22 Sabre reports Q3 adjusted EPS (25c), consensus (25c) 08/02/22 Sabre now sees FY22 revenue $2.3B-$2.6B at 50% bookings recovery 01/11/23 Veradigm sees FY23 EPS 90c-$1.00, consensus 95c 11/03/22 Allscripts backs FY22 Veradigm revenue growth view 6%-7% 11/03/22 Allscripts reports Q3 adjusted EPS 23c, consensus 19c 08/04/22 Allscripts backs FY22 Veradigm revenue growth view 6%-7% 10/27/22 Southwest sees FY22 ASMs down 4.5% 10/27/22 Southwest sees Q4 revenue up 13%-17%, consensus $6.23B 10/27/22 Southwest reports Q3 adjusted EPS 50c, consensus 42c 10/26/22 Notable companies reporting before tomorrow's open $22.92 / +2.145 (+10.32%)
11/01/22 Livent narrows FY22 revenue view to $815M-$845M from $800M-$860M 11/01/22 Livent reports Q3 EPS 41c, consensus 40c 08/02/22 Livent raises FY22 revenue to $800M-$860M from $755M-$835M 08/02/22 Livent reports Q2 GAAP EPS 31c, consensus 29c 12/22/22 CarMax reports Q3 EPS 24c, consensus 70c 12/21/22 Notable companies reporting before tomorrow's open 09/29/22 CarMax reports Q2 EPS 79c, consensus $1.39 10/28/22 JinkoSolar reports Q3 EPS 90c, consensus 71c 08/26/22 JinkoSolar reports Q2 EPS ($1.88), consensus 38c 10/25/22 JetBlue reports Q3 adjusted EPS 21c, consensus 24c 10/24/22 Notable companies reporting before tomorrow's open 09/16/22 JetBlue raises Q3 RASM growth view to 22%-24% year over three $256.98 / -14.31 (-5.27%)
01/11/23 Intuitive Surgical sees Q4 revenue $1.66B, consensus $1.68B 10/18/22 Intuitive Surgical reports Q3 EPS $1.19, consensus $1.12 07/21/22 Intuitive Surgical reports Q2 EPS $1.14, consensus $1.19 01/11/23 InMode sees FY23 revenue $525M-$530M, consensus $523.86M 01/11/23 InMode raises FY22 adjusted EPS view to $2.38-$2.39 from $2.28-$2.30 01/11/23 InMode sees Q4 adjusted EPS 73c-74c, consensus 65c 10/27/22 InMode sees FY22 adjusted EPS $2.28-$2.30, consensus $2.22 01/10/23 Halozyme sees FY23 adjusted EPS $2.50-$2.65, consensus $2.90 11/08/22 Halozyme reaffirms FY22 non-GAAP EPS view $2.10-$2.25, consensus $2.04 11/08/22 Halozyme reports Q3 non-GAAP EPS 74c, consensus 51c 08/09/22 Halozyme raises FY22 non-GAAP EPS view to $2.10-$2.25 from $2.05-$2.20 11/21/22 GDS Holdings reports Q3 EPS (3c), consensus (30c) 08/23/22 GDS Holdings sees 2022 revenue RMB 9.25B - RMB 9.4B 08/23/22 GDS Holdings reports Q2 EPS (32c), consensus (30c) 11/03/22 Franchise Group now sees FY22 EPS $3.25-$4.00, consensus $4.01 11/03/22 Franchise Group reports Q3 EPS 59c, consensus 71c 01/11/23 Ginkgo Bioworks backs FY22 revenue view $460M-$480M, consensus $470.79M 11/14/22 Ginkgo Bioworks sees FY22 revenue $425M-$440M, consensus $435.34M 11/14/22 Ginkgo Bioworks reports Q3 EPS (41c), consensus (30c) 08/15/22 Ginkgo Bioworks raises FY22 revenue view to $425M-$440M from $375M-$390M 11/08/22 Disney CFO sees FY23 cash content spend in low-$30B range 11/08/22 Disney reports Q4 EPS ex-items 30c, consensus 57c 11/08/22 Notable companies reporting after market close 08/10/22 Disney reports Q3 EPS ex-items $1.09, consensus $1.00 12/14/22 Delta Air Lines raises Q4 adjusted EPS view to $1.35-$1.40 from $1.00-$1.25 12/14/22 Delta Air Lines sees FY23 adjusted EPS $5.00-$6.00, consensus $4.80 12/14/22 Delta Air Lines sees FY22 revenue view $45.5B-$45.6B, consensus $45.54B 12/14/22 Delta Air Lines sees FY22 adjusted EPS $3.07-$3.12, consensus $2.89 11/30/22 Salesforce raises FY23 EPS view to $4.92-$4.94, consensus $4.73 11/30/22 Salesforce sees Q4 EPS $1.35-$1.37, consensus $1.34 11/30/22 Salesforce reports Q3 EPS $1.40, consensus $1.21 11/30/22 Notable companies reporting after market close 12/06/22 Conn's reports Q3 non-GAAP EPS (78c), consensus (83c) 10/18/22 Conn's withdraws FY23 financial guidance 10/18/22 Conn's sees Q3 revenue down 21%-23%, consensus $326.11M 08/30/22 Conn's reports Q2 adjusted EPS 4c, consensus 9c 01/10/23 Coinbase sees FY22 adjusted EBITDA within negative $500M loss 'guardrail' 12/07/22 Coinbase CEO tells Bloomberg 2022 revenue seen down 50% or more 11/03/22 Coinbase reports Q3 EPS ($2.43), consensus ($2.40) 10/25/22 Biogen raises FY22 EPS view to $16.50-$17.15, consensus $16.49 10/25/22 Biogen reports Q3 adjusted EPS $4.77, consensus $4.15 10/26/22 Boeing reports Q3 core EPS ($6.18), consensus 2c 10/25/22 Notable companies reporting before tomorrow's open 07/27/22 Boeing reports Q2 core EPS (37c), consensus (16c) 01/11/23 Axonics sees FY23 revenue $342M, consensus $327.2M 01/11/23 Axonics sees Q4 revenue $85.6M-$86.0M, consensus $74.3M 10/31/22 Axonics raises FY22 revenue view to $262M from $253M, consensus $254.0M 10/31/22 Axonics reports Q3 EPS (34c), consensus (48c) 10/20/22 Alaska Air sees FY22 capacity down 8%-9% vs. 2019 10/20/22 Alaska Air reports Q3 adjusted EPS $2.53, consensus $2.39 10/19/22 Notable companies reporting before tomorrow's open 10/20/22 American Airlines sees Q4 EPS ex-items 50c-70c, consensus 22c 10/20/22 American Airlines reports Q3 EPS 69c, consensus 56c
Earnings
Ginkgo reiterated its…
Ginkgo reiterated its expectations of 55-60 new Cell Programs added to the Foundry platform in 2022. Ginkgo continues to expect Total revenue of $460 - 480 million in 2022. Preliminary unaudited Foundry revenue is expected to be below the previously disclosed guidance of $150 - $170 million in 2022 due to a subset of targeted milestones remaining unearned in the fourth quarter, though Ginkgo remains confident in its ability to achieve these milestones. Preliminary unaudited Biosecurity revenue is expected to exceed the previously disclosed guidance of $310 million in 2022. Ginkgo launched Ginkgo Enzyme Services, which aims to solve challenges for R&D teams developing enzymes, from discovery of novel enzyme activity through optimization of enzyme function and large scale manufacturing. Ginkgo opened Bioworks7, which adds 6,600 square feet of Biosafety Level 2 lab space at Ginkgo's headquarters in Boston's Seaport District, expanding its mammalian foundry platform to provide significant runway to support new program additions in the pharma & biotech vertical. Ginkgo ended 2022 with approximately $1.3 billion of cash and cash equivalents, putting Ginkgo in a strong financial position to pursue its strategic objectives while driving towards profitability.
Show Hide Related Items >> <<
01/09/23 Ginkgo Bioworks, Prokarium announce RNA collaboration 01/06/23 Ginkgo Bioworks expands R&D facilities 01/05/23 Cathie Wood's ARK Investment bought 1.16M shares of Ginkgo Bioworks today 01/05/23 Ginkgo Bioworks, Esperovax announce partnership to develop circular RNAs 11/28/22 Berenberg Berenberg starts 'well-positioned' disruptor Ginkgo Bioworks with a Buy 11/28/22 Berenberg Ginkgo Bioworks initiated with a Buy at Berenberg 10/04/22 Morgan Stanley Ginkgo Bioworks initiated with an Equal Weight at Morgan Stanley 08/16/22 BTIG Ginkgo Bioworks price target raised to $6 from $5 at BTIG 11/14/22 Ginkgo Bioworks sees FY22 revenue $425M-$440M, consensus $435.34M 11/14/22 Ginkgo Bioworks reports Q3 EPS (41c), consensus (30c) 08/15/22 Ginkgo Bioworks raises FY22 revenue view to $425M-$440M from $375M-$390M 08/15/22 Ginkgo Bioworks reports Q2 EPS (41c), consensus (4c)
